Processing 00000000.tx.1: Insulin Inhibits Peroxisomal Fatty Acid Oxidation in Isolated Rat Hepatocytes1 Frederick G. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Peroxisomal Fatty Acid Oxidation in Isolated Rat Hepatocytes1 Frederick G."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   782   C1158366:fatty acid oxidation [Molecular Function]
   760   C0015684:Fatty acid [Lipid]
   739   C0001128:Acid [Chemical]
   739   C0030011:Oxidation [Molecular Function]
   739   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.2: Hamel2, Robert G. 

Phrase: "Hamel2,"

Phrase: "Robert G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.3: Bennett2, Jennifer L. 

Phrase: "Bennett2,"

Phrase: "Jennifer L."
Processing 00000000.tx.4: Upward and William C. 

Phrase: "Upward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282911:Upward [Spatial Concept]

Phrase: "and"

Phrase: "William C."
Processing 00000000.tx.5: Duckworth Research Service (F.G.H., R.G.B., J.L.U.), Department of Veterans Affairs Medical Center, Omaha, Nebraska 68105; 

Phrase: "Duckworth Research Service"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0557854:Service [Occupational Activity]
   827   C2825316:Service [Manufactured Object]
   827   C3245478:service [Idea or Concept]

Phrase: "(F.G.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0560020:g h [Quantitative Concept]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "R.G.B.,"

Phrase: "J.L.U."

Phrase: ")"

Phrase: ","

Phrase: "Department of Veterans Affairs Medical Center,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C3496098:Department of Veterans Affairs [Health Care Related Organization]
   827   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   827   C1549054:Veterans Affairs [Organization]
   827   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   799   C0042610:Veterans [Population Group]
   799   C0205099:Center [Spatial Concept]
   799   C0205476:Medical [Functional Concept]
   799   C1704729:Department [Organization]
   766 E C3245459:veteran [Intellectual Product]

Phrase: "Omaha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551450:Omaha [Population Group]

Phrase: "Nebraska 68105"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027523:Nebraska [Geographic Area]

Phrase: ";"
Processing 00000000.tx.6: Department of Internal Medicine (F.G.H., R.G.B.), Department of Pharmacology (F.G.H.), University of Nebraska Medical Center, Omaha, Nebraska 68198; 

Phrase: "Department of Internal Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "(F.G.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0560020:g h [Quantitative Concept]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "R.G."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0439267:g% [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Department of Pharmacology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "(F.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "University of Nebraska Medical Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0027523:Nebraska [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]

Phrase: "Omaha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551450:Omaha [Population Group]

Phrase: "Nebraska 68198"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027523:Nebraska [Geographic Area]

Phrase: ";"
Processing 00000000.tx.7: and Carl T. 

Phrase: "and"

Phrase: "Carl T."
Processing 00000000.tx.8: Hayden Medical Center (W.C.D.), Department of Veterans Affairs, Phoenix, Arizona 85012 Address all correspondence and requests for reprints to: Frederick G. 

Phrase: "Hayden Medical Center"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   901   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0205099:Center [Spatial Concept]
   827   C0205476:Medical [Functional Concept]

Phrase: "(W.C.D."

Phrase: ")"

Phrase: ","

Phrase: "Department of Veterans Affairs,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C3496098:Department of Veterans Affairs [Health Care Related Organization]
   861   C1549054:Veterans Affairs [Organization]
   812   C0042610:Veterans [Population Group]
   812   C1704729:Department [Organization]
   779 E C3245459:veteran [Intellectual Product]

Phrase: "Phoenix,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331993:Phoenix [Health Care Related Organization]
  1000   C1080696:Phoenix [Plant]

Phrase: "Arizona 85012"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003787:Arizona [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Frederick G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.9: Hamel, Ph.D., Department of Veterans Affairs Medical Center, 4101 Woolworth Avenue, Omaha, Nebraska 68105.  

Phrase: "Hamel,"

Phrase: "Ph.D.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1512022:Ph.D. [Intellectual Product]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "Department of Veterans Affairs Medical Center,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C3496098:Department of Veterans Affairs [Health Care Related Organization]
   827   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   827   C1549054:Veterans Affairs [Organization]
   827   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   799   C0042610:Veterans [Population Group]
   799   C0205099:Center [Spatial Concept]
   799   C0205476:Medical [Functional Concept]
   799   C1704729:Department [Organization]
   766 E C3245459:veteran [Intellectual Product]

Phrase: "4101 Woolworth Avenue,"

Phrase: "Omaha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551450:Omaha [Population Group]

Phrase: "Nebraska 68105."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027523:Nebraska [Geographic Area]
Processing 00000000.tx.10: Abstract Top Abstract Introduction Materials and Methods Results Discussion References  Inhibition by insulin of long chain fatty acid oxidation in mitochondria is mediated in part by elevating malonyl-CoA levels, which inhibit carnitine palmitoyl-transferase I. 

Phrase: "Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Inhibition by insulin of long chain fatty acid oxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   829   C2250059:inhibition of fatty acid oxidation [Cell Function]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "in mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "is"

Phrase: "mediated in part"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by elevating malonyl-CoA levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "carnitine palmitoyl-transferase I."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085966:Carnitine Palmitoyltransferase I [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258044:carnitine palmitoyltransferase I [Molecular Function]
   923   C0007262:Carnitine Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0729572:Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0021966:I- [Inorganic Chemical]
   812   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.11: Whether insulin alters peroxisomal oxidation has not been studied. 

Phrase: "Whether"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "peroxisomal oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.12: We present data which show that insulin inhibits the oxidation of palmitic acid by peroxisomes (IC50 = 8.5 x 10-11 M) at hormone concentrations 100-fold less than those needed for mitochondrial inhibition (IC50 = 1.3 x 10-8 M). 

Phrase: "We"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "which"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the oxidation of palmitic acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030011:Oxidation [Molecular Function]

Phrase: "by peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: "(IC50 = 8.5 x 10-11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0600495:IC50 [Quantitative Concept]

Phrase: "M) at hormone concentrations 100-fold less"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0019932:Hormone [Hormone]
   748   C0086045:Concentrations [Mental Process]
   748   C0332462:Fold [Spatial Concept]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1880834:FOLD [Phenomenon or Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "than those"

Phrase: "needed for mitochondrial inhibition"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0027552:Needed [Qualitative Concept]
   770   C0521451:Mitochondrial [Functional Concept]
   770   C0686904:needed [Functional Concept]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "(IC50 = 1.3 x 10-8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0600495:IC50 [Quantitative Concept]

Phrase: "M)."
Processing 00000000.tx.13: We used a purified peroxisome preparation to study the mechanism of insulin action. 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a purified peroxisome preparation to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0455052:Preparation [Health Care Activity]
   812   C1521827:Preparation [Functional Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the mechanism of insulin action."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0031327:mechanism of action [Physiologic Function]
   844   C1524059:mechanism of action [Functional Concept]
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.14: Insulin had a direct effect in the peroxisome preparations to decrease oxygen consumption, fatty acyl-CoA oxidizing system activity and acyl-CoA oxidase by approximately 40%, 30% and 15%, respectively. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "had"

Phrase: "a direct effect in the peroxisome preparations to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "oxygen consumption,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0030055:Oxygen Consumption [Clinical Attribute]
  1000   C1305742:oxygen consumption [Diagnostic Procedure]
   861   C0009830:Consumption [Activity]
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1947907:Consumption [Physiologic Function]

Phrase: "fatty acyl-CoA oxidizing system activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "acyl-CoA oxidase by approximately 40%,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0050690:acyl-CoA oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1412128:ACYL-CoA OXIDASE [Gene or Genome]
   833   C2984960:Acyl CoA Oxidase [Laboratory Procedure]
   790   C0001374:Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "30%"

Phrase: "and"

Phrase: "15%,"

Phrase: "respectively."
Processing 00000000.tx.15: Since insulin degrading enzyme (IDE) is an insulin-binding protein known to be in peroxisomes, we studied the effect of an inhibitory anti-IDE antibody on the ability of insulin to inhibit the fatty acyl-CoA oxidizing system. 

Phrase: "Since"

Phrase: "insulin degrading enzyme (IDE)"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "an insulin-binding protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1623517:insulin binding [Molecular Function]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be in peroxisomes,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0752063:Peroxisomes [Cell Component]
   790   C2987476:Be [Conceptual Entity]
   756 E C2984308:Peroxisome [Functional Concept]
   706 E C3546463:peroxisomal [Cell Component]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the effect of an inhibitory anti-IDE antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "on the ability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085732:Ability [Organism Attribute]
   928 E C1299581:Able [Finding]

Phrase: "of insulin to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the fatty acyl-CoA oxidizing system."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]
   717   C0001374:Fatty Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.16: The antibody eliminated the inhibitory effect of insulin. 

Phrase: "The antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "the inhibitory effect of insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.17: We conclude that insulin inhibits peroxisomal fatty acid oxidation by a mechanism requiring IDE.  

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "peroxisomal fatty acid oxidation by a mechanism requiring IDE."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   775   C1158366:fatty acid oxidation [Molecular Function]
   756   C0015684:Fatty acid [Lipid]
   738   C0001128:Acid [Chemical]
   738   C0030011:Oxidation [Molecular Function]
   738   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.18: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  TYPE 2 DIABETES mellitus is no longer seen as simply a disease of carbohydrate metabolism (1, 2). 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TYPE 2 DIABETES mellitus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
  1000   C2984301:Type II diabetes mellitus [Functional Concept]
   875   C1320657:type diabetes [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "no longer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205166:Long [Qualitative Concept]
   966   C1706317:Long [Qualitative Concept]

Phrase: "seen as simply"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "a disease of carbohydrate metabolism"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   926   C0149670:Disease of carbohydrate metabolism [Disease or Syndrome]
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.19: Lipid metabolism, especially that of FFA, plays an important role (1, 3, 4). 

Phrase: "Lipid metabolism,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598783:Lipid Metabolism [Molecular Function]
  1000   C1517898:Lipid Metabolism [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "especially"

Phrase: "that of FFA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015688:FFA [Lipid]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.20: The interaction of FFA and glucose metabolism was first noted by Randles group in the 1960s (5), in what is called the glucose-fatty acid cycle. 

Phrase: "The interaction of FFA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "noted by Randles group"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   737   C1316572:Note [Clinical Attribute]
   737   C1317574:Note [Intellectual Product]
   737   C1369612:Note [Clinical Attribute]

Phrase: "in the 1960s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681755:1960s [Temporal Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "in what"

Phrase: "is"

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "the glucose-fatty acid cycle."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1511572:Cycle [Temporal Concept]
Processing 00000000.tx.21: Essentially, increased availability of one substrate would suppress oxidation of the other. 

Phrase: "Essentially,"

Phrase: "increased availability of one substrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0470187:Availability of [Functional Concept]
           Availability

Phrase: "would"

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "oxidation of the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030011:Oxidation [Molecular Function]

Phrase: "other."
Processing 00000000.tx.22: Increased FFA oxidation results in increased acetyl CoA and citrate, which inhibit pyruvate dehydrogenase and phosphofructokinase 1, respectively. 

Phrase: "Increased FFA oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030011:Oxidation [Molecular Function]

Phrase: "results in increased acetyl CoA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "and"

Phrase: "citrate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008857:Citrate [Organic Chemical]
  1000   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "which"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "pyruvate dehydrogenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "and"

Phrase: "phosphofructokinase 1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0031651:Phosphofructokinase-1 [Amino Acid, Peptide, or Protein,Enzyme]
           Phosphofructokinase
  1000   C0969688:Phosphofructokinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150453:phosphofructokinase 1 [Molecular Function]
   861   C0162449:PHOSPHOFRUCTOKINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "respectively."
Processing 00000000.tx.23: More recent studies have confirmed that increased FFAs cause more lipid oxidation and less carbohydrate utilization (6, 7, 8, 9). 

Phrase: "More recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that increased FFAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015688:ffas [Lipid]
   861   C1708011:FFAS [Intellectual Product]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "more lipid oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2612546:lipid oxidation [Molecular Function]
   827   C0023779:Lipid [Lipid]
   827   C0030011:Oxidation [Molecular Function]

Phrase: "and"

Phrase: "less carbohydrate utilization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1160589:carbohydrate utilization [Cell Function]
   827   C0042153:utilization [Functional Concept]

Phrase: "(6,"

Phrase: "7,"

Phrase: "8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.24: Thus, insulin control of FFA metabolism may be a critical factor in the etiology of type 2 diabetes. 

Phrase: "Thus,"

Phrase: "insulin control of FFA metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "a critical factor in the etiology of type 2 diabetes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   757   C0960756:factor A [Organic Chemical]
   739   C1521761:Factor [Functional Concept]
   739   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.25: Insulin decreases fatty acid oxidation, in part, by decreasing triglyceride breakdown, and thereby reducing substrate availability. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "fatty acid oxidation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "by decreasing triglyceride breakdown,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1157922:triglyceride breakdown [Molecular Function]
   827   C0443161:break down [Qualitative Concept]
   827   C0699900:breakdown [Organism Function]
   827   C1265875:breakdown [Acquired Abnormality]

Phrase: "and"

Phrase: "thereby"

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "substrate availability."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470187:Availability [Functional Concept]
Processing 00000000.tx.26: Insulin also has direct effects on fatty acid oxidation. 

Phrase: "Insulin also"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "direct effects on fatty acid oxidation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.27: Fatty acids are metabolized in mitochondria and peroxisomes. 

Phrase: "Fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "metabolized in mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1524026:Metabolized [Cell Function]

Phrase: "and"

Phrase: "peroxisomes."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]
Processing 00000000.tx.28: Long chain fatty acids require coupling to carnitine for transport into the organelles matrix before oxidation (10, 11, 12). 

Phrase: "Long chain fatty acids"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   966   C0522095:Long chain fatty acid [Biologically Active Substance,Lipid]
   861   C0015684:Fatty Acids [Lipid]
   812   C0001128:Acids [Chemical]
   812   C0205166:Long [Qualitative Concept]
   812   C0337112:Chain [Manufactured Object]
   812   C1524075:Chain [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "require"

Phrase: "coupling to carnitine"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]
   790   C1948027:Coupling [Functional Concept]
   756 E C0010222:couple [Family Group]

Phrase: "for transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "into the organelles matrix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "before oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "(10,"

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.29: This coupling is catalyzed by carnitine palmitoyl-transferase I (CPT I). 

Phrase: "This coupling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948027:Coupling [Functional Concept]

Phrase: "is"

Phrase: "catalyzed by carnitine palmitoyl-transferase I (CPT I)."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0085966:Carnitine Palmitoyltransferase I [Amino Acid, Peptide, or Protein,Enzyme]
   882   C2258044:carnitine palmitoyltransferase I [Molecular Function]
   833   C0007262:Carnitine Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0729572:Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0021966:I- [Inorganic Chemical]
   753   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.30: Malonyl-CoA, a by-product of glucose metabolism, is a potent inhibitor of CPT I (13). 

Phrase: "Malonyl-CoA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024645:Malonyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "a by-product of glucose metabolism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0017725:Glucose product [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]

Phrase: "is"

Phrase: "a potent inhibitor of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1999216:Inhibitor [Qualitative Concept]

Phrase: "CPT I"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0085966:Carnitine Palmitoyltransferase I [Amino Acid, Peptide, or Protein,Enzyme]
   882   C2258044:carnitine palmitoyltransferase I [Molecular Function]
   833   C0007262:Carnitine Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0729572:Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0021966:I- [Inorganic Chemical]
   753   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.31: Insulins ability to decrease mitochondrial fatty acid oxidation is thought to be mediated by this mechanism. 

Phrase: "Insulins ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "mitochondrial fatty acid oxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1158366:fatty acid oxidation [Molecular Function]
   861   C0015684:Fatty acid [Lipid]
   812   C0001128:Acid [Chemical]
   812   C0030011:Oxidation [Molecular Function]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "mediated by this mechanism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.32: However, much less is known about the mechanism whereby insulin reduces peroxisomal oxidation. 

Phrase: "However,"

Phrase: "much less"

Phrase: "is"

Phrase: "known about the mechanism whereby insulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205309:Known [Qualitative Concept]
   753   C0441712:Mechanism [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "reduces"

Phrase: "peroxisomal oxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.33: Peroxisomes oxidize a variety of lipids through -oxidation, including medium, long-chain, and very long-chain fatty acids, branched fatty acids, dicarboxylic acids, prostaglandins, and some bile acids (14). 

Phrase: "Peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: "oxidize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:oxidize [Molecular Function]

Phrase: "a variety of lipids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883525:Variety [Conceptual Entity]
   770   C2346866:Variety [Conceptual Entity]

Phrase: "through -oxidation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "long-chain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205166:Long [Qualitative Concept]
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]
   861   C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "very long-chain fatty acids,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0443566:very long chain fatty acids [Laboratory Procedure]
   966 E C0542549:Very long chain fatty acid [Lipid]
   904   C0522095:Long chain fatty acid [Biologically Active Substance,Lipid]
   884   C1980013:Very long chain [Qualitative Concept]
   840   C0015684:Fatty Acids [Lipid]
   804   C0001128:Acids [Chemical]
   804   C0205166:Long [Qualitative Concept]
   804   C0337112:Chain [Manufactured Object]
   804   C0442824:Very [Qualitative Concept]
   804   C1524075:Chain [Idea or Concept]
   804   C1706317:Long [Qualitative Concept]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: "branched"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1253959:branched [Body Part, Organ, or Organ Component]
  1000   C2700384:Branched [Spatial Concept]
   966 E C1881507:Branch [Chemical Viewed Structurally]
   966 E C2700383:Branch [Plant]
   966 E C2826234:BRANCH [Intellectual Product]

Phrase: "fatty acids,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "dicarboxylic acids,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0012063:Dicarboxylic Acids [Organic Chemical]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "prostaglandins,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0033554:Prostaglandins [Biologically Active Substance,Eicosanoid,Pharmacologic Substance]
   966 E C1266240:Prostaglandin [Laboratory Procedure]

Phrase: "and"

Phrase: "some bile acids"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0005390:Bile Acids [Biologically Active Substance,Steroid]
  1000   C0523530:Bile Acids [Laboratory Procedure]
   966 E C2917673:Bile Acid [Pharmacologic Substance]
   955 E C0376167:Choleic Acid [Biologically Active Substance,Pharmacologic Substance,Steroid]
   861   C0001128:Acids [Chemical]
   861   C0005388:Bile [Body Substance]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.34: Normally peroxisomal -oxidation of fatty acids is preferential for very long-chain fatty acids (>C20), although oxidation of shorter chains occurs. 

Phrase: "Normally peroxisomal -oxidation of fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   814   C1158366:acids fatty oxidation [Molecular Function]
   753   C0030011:Oxidation [Molecular Function]

Phrase: "is"

Phrase: "preferential for very long-chain fatty acids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   731   C0443566:very long chain fatty acids [Laboratory Procedure]
   704 E C0542549:Fatty acids.very long chain [Lipid]

Phrase: "("

Phrase: ">C20"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "oxidation of shorter chains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030011:Oxidation [Molecular Function]

Phrase: "occurs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.35: Peroxisomal -oxidation has many similarities to the analogous mitochondrial process (14), but peroxisomal -oxidation is not coupled to the electron transport chain. 

Phrase: "Peroxisomal -oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "has"

Phrase: "many similarities to the analogous mitochondrial process"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C2348205:Similarity [Qualitative Concept]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "peroxisomal -oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "coupled to the electron transport chain."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C2244392:electron transport chain [Molecular Function]
   790   C0013846:Electron Transport [Molecular Function]
   783   C1550030:Transport To [Idea or Concept]
   753   C0005528:Transport, NOS [Cell Function]
   753   C0013852:Electron [Quantitative Concept]
   753   C0337112:Chain [Manufactured Object]
   753   C1317949:Transport [Manufactured Object]
   753   C1524075:Chain [Idea or Concept]
   753   C1948027:Coupled [Functional Concept]
   753   C3463986:Electron [Bird]
   753   C3495449:transport [Medical Device]
   719 E C0010222:couple [Family Group]
Processing 00000000.tx.36: Instead, the by-products are heat, FADH2, and H2O2. 

Phrase: "Instead,"

Phrase: "the by-products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0006539:BY [Geographic Area]
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "are"

Phrase: "heat,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "FADH2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0044036:FADH2 [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "H2O2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.37: We have examined insulins effect on peroxisomal FA oxidation in isolated hepatocytes. 

Phrase: "We"

Phrase: "have"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "insulins effect on peroxisomal FA oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in isolated hepatocytes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0227525:Hepatocytes [Cell]
   827 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.38: Further, we have done studies on isolated peroxisomes to explore the mechanism of the insulin effect. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "we"

Phrase: "have"

Phrase: "done"

Phrase: "studies on isolated peroxisomes to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "explore"

Phrase: "the mechanism of the insulin effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.39: Our results indicate that peroxisomal FA oxidation is controlled by insulin in a manner different from mitochondria FA oxidation.  

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that peroxisomal FA oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030011:Oxidation [Molecular Function]

Phrase: "is"

Phrase: "controlled by insulin"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   882   C0332298:Controlled by [Functional Concept]
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C2587213:Controlled [Functional Concept]
   756 E C0243148:control [Qualitative Concept]
   756 E C1550141:Control [Substance]
   756 E C1882979:Control [Conceptual Entity]
   756 E C3274648:Control [Qualitative Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in a manner"

Phrase: "different from mitochondria FA oxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.40: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Porcine crystalline insulin and insulin mono- 125-iodinated on residue A14 were gifts of Ronald Chance and Bruce Frank, both of Eli Lilly & Co. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Porcine crystalline insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   913   C0724601:Porcine Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   913   C0770206:Porcine insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0444626:Crystalline [Chemical Viewed Structurally]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin mono- 125-"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1551432:Mono [Population Group]
   827   C1551969:Mono [Language]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "iodinated on residue A14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709915:Residue [Conceptual Entity]
   770   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "were"

Phrase: "gifts of Ronald Chance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237506:Chance [Qualitative Concept]
   770   C1136188:Gifts [Entity]

Phrase: "and"

Phrase: "Bruce Frank,"

Phrase: "both of Eli Lilly & Co."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0331851:Eli Lilly [Health Care Related Organization]
   760   C0238767:Both [Spatial Concept]
   760   C1706086:Both [Qualitative Concept]
Processing 00000000.tx.41: (Indianapolis, IN). 

Phrase: "(Indianapolis,"

Phrase: "IN"

Phrase: ")."
Processing 00000000.tx.42: Palmitic acid [14C-1] was purchased from Amersham Pharmacia Biotech (Piscataway, NJ). 

Phrase: "Palmitic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030234:Palmitic Acid [Biologically Active Substance,Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "[14C-1"

Phrase: "]"

Phrase: "was"

Phrase: "purchased from Amersham Pharmacia Biotech"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0331955:Pharmacia [Health Care Related Organization]
   760   C0869011:purchased [Activity]

Phrase: "(Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.43: Octanoic acid [14C-1] and arachidonic acid [14C-1] were purchased from American Radiolabeled Chemicals Inc. 

Phrase: "Octanoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054616:octanoic acid [Lipid,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "[14C-1"

Phrase: "]"

Phrase: "and"

Phrase: "arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "[14C-1"

Phrase: "]"

Phrase: "were"

Phrase: "purchased from American Radiolabeled Chemicals Inc."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0220806:Chemicals [Chemical]
   753   C0596070:American [Population Group]
   753   C0869011:purchased [Activity]
   753   C1527121:Radiolabeled [Qualitative Concept]
   719 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]
   719 E C3272558:Chemical [Intellectual Product]
Processing 00000000.tx.44: (St. Louis, MO). 

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.45: Percoll was from Amersham Pharmacia Biotech. 

Phrase: "Percoll"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was from Amersham Pharmacia Biotech."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0331955:Pharmacia [Health Care Related Organization]
   760   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.46: Leuco-DCF (2,7-dichlorodihydrofluorescein diacetate) was from Molecular Probes, Inc. 

Phrase: "Leuco-DCF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030896:DCF [Antibiotic,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "7-dichlorodihydrofluorescein diacetate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0369114:Diacetate [Organic Chemical]

Phrase: ")"

Phrase: "was from Molecular Probes,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0182400:Probes [Medical Device]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]
   770   C1521991:Molecular [Qualitative Concept]
   737 E C1704681:Probe [Gene or Genome]
   737 E C2347609:Probe [Chemical Viewed Functionally]
   737 E C3536729:Probe [Manufactured Object]

Phrase: "Inc."
Processing 00000000.tx.47: (Eugene, OR). 

Phrase: "(Eugene,"

Phrase: "OR"

Phrase: ")."
Processing 00000000.tx.48: Palmitoyl Co-A was from Sigma (St. Louis, MO). 

Phrase: "Palmitoyl Co-A"

Phrase: "was from Sigma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
   790   C1719918:Sigma [Intellectual Product]

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.49: All other chemicals were reagent grade or better. 

Phrase: "All"

Phrase: "other chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were"

Phrase: "reagent grade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441800:Grade [Classification]
   861   C0919553:Grade [Classification]
   861   C3244287:grade [Finding]

Phrase: "or"

Phrase: "better."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332272:Better [Qualitative Concept]
Processing 00000000.tx.50: BSA (Fraction V) was defatted by treatment with activated charcoal under acidic conditions as previously described (15). 

Phrase: "BSA (Fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "V)"

Phrase: "was"

Phrase: "defatted by treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with activated charcoal"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0001275:Activated Charcoal [Organic Chemical,Pharmacologic Substance]
   861   C0007955:Charcoal [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1879547:Activated [Activity]
   827 E C1515877:Activate [Functional Concept]

Phrase: "under acidic conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.51: Preparation of isolated rat hepatocytes Hepatocytes were isolated from fasted male Sprague Dawley rats (Charles River Laboratories, Wilmington, MA) (150250 g) by collagenase perfusion using a modification of the method of Peavy et al. 

Phrase: "Preparation of isolated rat hepatocytes Hepatocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0455052:Preparation [Health Care Activity]
   753   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "isolated from fasted male Sprague Dawley rats"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   814   C0034715:Rats, Sprague-Dawley [Mammal]
   778   C2699239:Sprague-Dawley [Mammal]
   748   C0024554:Male [Finding]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0086582:male [Population Group]
   748   C0205409:Isolated [Functional Concept]
   748   C1548221:Isolated [Idea or Concept]
   748   C1706180:Male [Qualitative Concept]
   748   C1706428:Male [Qualitative Concept]
   748   C1706429:Male [Organism Attribute]
   714   C0015663:Fast [Finding]
   714 E C0370215:Isolate [Substance]
   714   C0456962:Fast [Qualitative Concept]
   714 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(Charles River Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Wilmington,"

Phrase: "MA) (150250 g) by collagenase perfusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a modification of the method of Peavy et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392747:Modification [Functional Concept]
   742   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.52: (16). 

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.53: Before assay, the cells were resuspended at 2 x 106 cells/ml in Krebs Improved Ringer II buffer with 2% BSA and incubated for 30 min at 37 C with constant flow of O2/CO2 (95/5). 

Phrase: "Before assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "resuspended"

Phrase: "at 2 x 106 cells/ml in Krebs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C2699156:Cells/mL [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]

Phrase: "Improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "Ringer II buffer with 2% BSA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "incubated for 30 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37 C"

Phrase: "with constant flow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "of O2/CO2 (95/5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: ")."
Processing 00000000.tx.54: Cellular fatty acid oxidation Fatty acid oxidation was measured by a modification of the method of Mannaerts et al. 

Phrase: "Cellular fatty acid oxidation Fatty acid oxidation"

Phrase: "was"

Phrase: "measured by a modification of the method of Mannaerts et al."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   754   C0217843:ET-A [Amino Acid, Peptide, or Protein,Receptor]
   738   C0025663:Method [Intellectual Product]
   738   C0392747:Modification [Functional Concept]
   738   C0444706:Measured [Qualitative Concept]
   738   C0449851:Method [Functional Concept]
   738   C0871511:METHOD [Intellectual Product]
   738   C1554963:modification [Qualitative Concept]
   738   C3541902:MEASURED [Diagnostic Procedure]
   704 E C0079809:Measure [Quantitative Concept]
   704 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.55: (17). 

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.56: Isolated hepatocytes (0.25 ml) were incubated for 1 h in scintillation vials in Krebs Improved Ringer II buffer with 2% defatted BSA (except where noted), with 1 mM fatty acid (palmitic, arachidonic or oleic; specific activity 1 Ci/mol). 

Phrase: "Isolated hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0227525:Hepatocytes [Cell]
   827 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(0.25 ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in scintillation vials"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0184301:vials [Medical Device]
   861   C1533199:Vials [Quantitative Concept]
   827 E C1706497:VIAL [Medical Device]

Phrase: "in Krebs"

Phrase: "Improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "Ringer II buffer with 2% defatted BSA ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "except where"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "with 1 mM fatty acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0015684:Fatty acid [Lipid]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "(palmitic, arachidonic"

Phrase: "or"

Phrase: "oleic"

Phrase: "; specific activity 1 Ci/mol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   804   C0027960:Mole [Neoplastic Process]
   804   C0324740:Mole [Mammal]
   804   C0439189:Mole [Quantitative Concept]
   804   C1456781:mole [Neoplastic Process]
   804   C1824986:mol [Gene or Genome]
   721 E C0026367:Molar [Body Part, Organ, or Organ Component]
   704 E C0027962:moles [Neoplastic Process]

Phrase: ")."
Processing 00000000.tx.57: Insulin was included at various concentrations as shown in the figures. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "included at various concentrations"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0086045:Concentrations [Mental Process]
   770   C0332257:included [Functional Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1446561:Concentration [Quantitative Concept]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "as"

Phrase: "shown in the figures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.58: The peroxisomal component was determined by adding 3 mM KCN to corresponding vials to inhibit mitochondrial oxidation. 

Phrase: "The peroxisomal component"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1820046:peroxisome component [Cell Component]
   861   C0449432:Component [Manufactured Object]
   861   C1705248:Component [Conceptual Entity]

Phrase: "was"

Phrase: "determined by adding 3 mM KCN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1883712:Add [Functional Concept]

Phrase: "to corresponding vials to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0184301:vials [Medical Device]
   827   C1533199:Vials [Quantitative Concept]
   793 E C1706497:VIAL [Medical Device]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "mitochondrial oxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.59: Radiolabeled CO2 was collected in center wells with Whatman #1 filter paper and 300 l of 1 M methylbenzethonium hydroxide in methanol. 

Phrase: "Radiolabeled CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "collected in center wells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205099:Center [Spatial Concept]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   737   C0205170:Well [Qualitative Concept]
   737   C3146287:Well [Manufactured Object]

Phrase: "with Whatman #1 filter paper"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   861   C0180859:filter paper [Medical Device]
   812   C0030351:Paper [Manufactured Object]
   812   C0180860:Filter [Manufactured Object]
   812   C0581406:Filter [Medical Device]
   812   C1522664:Filter [Intellectual Product]
   812   C1547566:Paper [Idea or Concept]
   812   C1704449:Filter [Conceptual Entity]
   812   C1704684:Filter [Medical Device]
   812   C1875155:FILTER [Medical Device]
   756 E C0080194:Strain [Injury or Poisoning]
   756 E C0442694:Straining [Physiologic Function]
   756 E C0456178:strain [Intellectual Product]
   756 E C1518614:Strain [Organism]
   756 E C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "300 l of 1 M methylbenzethonium hydroxide"

Phrase: "in methanol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.60: At the end of the incubation, 300 l of 5 M H2SO4 was added to volatilize the remaining CO2, and the solution incubated another 30 min. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the incubation,"

Phrase: "300 l of 5 M H2SO4"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "volatilize"

Phrase: "the remaining CO2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "the solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "another 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.61: The center wells were then placed in other scintillation vials and 8 ml of aqueous scintillant added and counted on a  counter. 

Phrase: "The center wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "placed in other scintillation vials"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0184301:vials [Medical Device]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1533199:Vials [Quantitative Concept]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726 E C1706497:VIAL [Medical Device]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "8 ml of aqueous scintillant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "counted on a  counter."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0677601:Counter [Manufactured Object]
   770   C1705206:Counter [Medical Device]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.62: Preparation of rat liver peroxisomes Male Sprague Dawley rats (150250 g) were fasted overnight, killed by decapitation, livers removed, and peroxisomes were prepared as described (18). 

Phrase: "Preparation of rat liver peroxisomes Male Sprague Dawley rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0023899:Liver preparation [Organic Chemical,Pharmacologic Substance]
   742   C0455052:Preparation [Health Care Activity]
   742   C1521827:Preparation [Functional Concept]

Phrase: "(150250 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "fasted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015663:Fast [Finding]
   966   C0456962:Fast [Qualitative Concept]

Phrase: "overnight,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "killed by decapitation,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0152232:Decapitation [Injury or Poisoning]
   790   C0162388:killed [Social Behavior]
   790   C0413398:Decapitation [Injury or Poisoning]
   756 E C0681205:Kill [Idea or Concept]
   756 E C1550555:kill [Functional Concept]

Phrase: "livers"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0023884:Livers [Body Part, Organ, or Organ Component]
   966 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   966 E C1278929:Liver [Body Part, Organ, or Organ Component]
   966 E C2346688:LIVER [Food]
   928 E C0205054:Hepatic [Body Location or Region]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: "were"

Phrase: "prepared as described"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552738:described [Idea or Concept]
   756   C1521827:Prepare [Functional Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.63: Briefly, the livers were homogenized, and subcellular fractionation was performed to produce nuclear/heavy mitochondrial (N/M), light mitochondrial (L), microsomal (P), and cytosolic (S) fractions. 

Phrase: "Briefly,"

Phrase: "the livers"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0023884:Livers [Body Part, Organ, or Organ Component]
   966 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   966 E C1278929:Liver [Body Part, Organ, or Organ Component]
   966 E C2346688:LIVER [Food]
   928 E C0205054:Hepatic [Body Location or Region]

Phrase: "were"

Phrase: "homogenized"

Phrase: ","

Phrase: "and"

Phrase: "subcellular fractionation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1656251:subcellular fractionation [Laboratory Procedure]
   861   C0016640:fractionation [Laboratory Procedure]
   861   C0524811:fractionation [Therapeutic or Preventive Procedure]
   861   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "nuclear/heavy mitochondrial (N/M), light mitochondrial"

Phrase: "(L), microsomal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1979928:Microsomal [Qualitative Concept]
   789 E C0026029:Microsome [Cell Component]

Phrase: "(P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cytosolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosolic [Cell Component]

Phrase: "("

Phrase: "S)"

Phrase: "fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.64: The L fraction, containing light mitochondria, lysosomes, and peroxisomes, was further purified by Percoll density gradient centrifugation (18). 

Phrase: "The L fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "light mitochondria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026237:Mitochondria [Cell Component]

Phrase: "lysosomes,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "and"

Phrase: "peroxisomes,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "purified by Percoll density gradient centrifugation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0007704:Centrifugation, Density Gradient [Laboratory Procedure]
   820   C0430994:Percoll gradient centrifugation [Laboratory Procedure]
   753   C0007703:Centrifugation [Laboratory Procedure]
   753   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0178587:density [Quantitative Concept]
   753   C0439182:% gradient [Quantitative Concept]
   753   C0812409:Gradient [Quantitative Concept]
   753   C1998793:Purified [Functional Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.65: Fractions containing peroxisomal marker activity were pooled, and Percoll was removed by centrifugation. 

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "peroxisomal marker activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: ","

Phrase: "and"

Phrase: "Percoll"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "removed by centrifugation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]
Processing 00000000.tx.66: The Percoll-purified peroxisome (PPP) fractions were used for further studies of peroxisomal -oxidation and the effect of insulin. 

Phrase: "The Percoll-purified peroxisome"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0752063:Peroxysome [Cell Component]
   827   C2984308:Peroxisome [Functional Concept]
   755 E C3546463:peroxisomal [Cell Component]

Phrase: "(PPP) fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "used for further studies of peroxisomal -oxidation"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   757   C0869040:Use studies [Research Activity]
   757   C1524063:Use of [Functional Concept]
   748   C0030011:Oxidation [Molecular Function]
   748   C0947630:studies [Laboratory Procedure]
   748   C1273517:used [Finding]
   748   C1517331:Further [Spatial Concept]
   748   C3546463:peroxisomal [Cell Component]
   714 E C0042153:use [Functional Concept]
   714 E C0205108:far [Spatial Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C0557651:Study [Manufactured Object]
   714 E C1947944:Use [Intellectual Product]
   714 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "the effect of insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.67: Enzyme assays Marker enzymes catalase (19), fatty acyl-CoA oxidizing system (FAOS), (20), and acyl-CoA oxidase (AOX) (21) (peroxisomes), acid phosphatase (22) (lysosomes), lactate dehydrogenase (19) (cytosol), cytochrome-c oxidase (19) (mitochondria), 5'-nucleotidase (23) (plasma membrane), glucose-6-phosphatase (23) (endoplasmic reticulum), and -mannosidase II (19) (Golgi) were measured as described. 

Phrase: "Enzyme assays Marker enzymes catalase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1413138:CATALASE [Gene or Genome]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "fatty acyl-CoA oxidizing system (FAOS),"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]
   717   C0001374:Fatty Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "acyl-CoA oxidase (AOX)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0050690:acyl-CoA oxidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412128:ACYL-CoA OXIDASE [Gene or Genome]
  1000   C2984960:Acyl CoA Oxidase [Laboratory Procedure]
   901   C0001374:Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(21"

Phrase: ")"

Phrase: "(peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "acid phosphatase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001109:Acid Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001128:Acid [Chemical]
   861   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0202406:Acid [Laboratory Procedure]
   861   C1149880:phosphatase [Molecular Function]

Phrase: "(22"

Phrase: ")"

Phrase: "(lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: ")"

Phrase: ","

Phrase: "lactate dehydrogenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "(19"

Phrase: ")"

Phrase: "(cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "cytochrome-c oxidase"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0010760:CYTOCHROME C OXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
           Cytochrome Oxidase
   901   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   901   C1153524:cytochrome c [Molecular Function]
   901   C1426584:CYTOCHROME C [Gene or Genome]
   827   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325304:cytochrome [Molecular Function]

Phrase: "(19"

Phrase: ")"

Phrase: "(mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "5'-nucleotidase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0000530:5'-NUCLEOTIDASE [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C0312402:5'-Nucleotidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0028625:nucleotidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0220883:nucleotidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "(plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "glucose-6-phosphatase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017755:GLUCOSE-6-PHOSPHATASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1149880:phosphatase [Molecular Function]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "(endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "and -"

Phrase: "mannosidase II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284655:Mannosidase II [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(19"

Phrase: ")"

Phrase: "(Golgi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018042:Golgi [Cell Component]

Phrase: ")"

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]
Processing 00000000.tx.68: Oxygen consumption by isolated peroxisomes was performed as described (24) with a Gilson oxygraph equipped with a Clark electrode, using palmitoyl CoA as the substrate. 

Phrase: "Oxygen consumption by isolated peroxisomes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0030055:Oxygen Consumption [Clinical Attribute]
   806   C1305742:oxygen consumption [Diagnostic Procedure]
   760   C0009830:Consumption [Activity]
   760   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1947907:Consumption [Physiologic Function]

Phrase: "was"

Phrase: "performed as described"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(24"

Phrase: ")"

Phrase: "with a Gilson oxygraph"

Phrase: "equipped with a Clark electrode,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0013812:electrode [Medical Device]
   760   C1705652:Electrode [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "palmitoyl CoA as the substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0030239:Palmitoyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.69: Insulin degradation was measured as described (25). 

Phrase: "Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "measured as described"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C1552738:described [Idea or Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.70: Protein was measured by the method of Bradford (26). 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "measured by the method of Bradford"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0025663:Method [Intellectual Product]
   753   C0444706:Measured [Qualitative Concept]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.71: Some of the studies used our monoclonal antibody C203.1A, which we have previously shown inhibits IDE (27, 28). 

Phrase: "Some of the studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C3540770:Some [Intellectual Product]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "our monoclonal antibody C203.1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0450344:1A [Intellectual Product]
   812   C1553633:1a [Medical Device]

Phrase: "which"

Phrase: "we"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.72: Statistical analyses One-way ANOVA with Bonferronis post test on selected pairs or t test, (as appropriate) were performed using GraphPad Software, Inc. 

Phrase: "Statistical analyses One-way ANOVA with Bonferronis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   814   C1709320:One-way ANOVA [Quantitative Concept]

Phrase: "post test on selected pairs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C0687676:Post [Temporal Concept]
   760   C1704687:Post [Manufactured Object]
   760   C1709450:Pair [Qualitative Concept]
   726   C1707391:Select [Activity]

Phrase: "or"

Phrase: "t test,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0871472:t-Test [Intellectual Product]
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: "("

Phrase: "as appropriate"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548787:Appropriate [Qualitative Concept]
   928 E C0814634:appropriateness [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GraphPad Software,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "Inc."
Processing 00000000.tx.73: Prism version 3.02 for Windows, (San Diego, CA, www.graphpad.com). 

Phrase: "Prism version 3.02 for Windows,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0333052:Version [Functional Concept]
   753   C0557702:windows [Manufactured Object]
   753   C0814195:PRISM [Intellectual Product]
   753   C2607870:Version [Spatial Concept]
   719 E C1272706:Window [Temporal Concept]
   719 E C1704674:Window [Manufactured Object]

Phrase: "(San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA,"

Phrase: "www.graphpad.com"

Phrase: ")."
Processing 00000000.tx.74: Curve fitting of means to a one site competition model was also done with Prism. 

Phrase: "Curve fitting of means"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0036572:Fitting [Sign or Symptom]
   770   C0205134:Curve [Spatial Concept]
   770   C0441548:Fitting [Health Care Activity]
   737 E C0424576:Fit [Finding]
   737 E C2349186:Fit [Activity]

Phrase: "to a one site competition model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "also"

Phrase: "done with Prism."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0814195:PRISM [Intellectual Product]
   790   C1272695:Done [Qualitative Concept]
   790   C2746065:Done [Temporal Concept]
   734 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.75: All values shown are means  SEM. 

Phrase: "All values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "means  SEM."
Processing 00000000.tx.76: The numbers of independent experiments are indicated in the figure legends.  

Phrase: "The numbers of independent experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "are"

Phrase: "indicated in the figure legends."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1444656:Indicated [Finding]
   726   C2729544:Legend [Pharmacologic Substance]
Processing 00000000.tx.77: Results Top Abstract Introduction Materials and Methods Results Discussion References  Insulin inhibited total palmitic acid oxidation to CO2 by 50% at 10-7 M, the maximum concentration tested, with an apparent IC50 of 1.3 x 10-8 M (Fig. 1, upper panel). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "total palmitic acid oxidation to CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030011:Oxidation [Molecular Function]

Phrase: "by 50%"

Phrase: "at 10-7 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "the maximum concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C2347813:Maximum Concentration [Quantitative Concept]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "with an apparent IC50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "of 1.3 x 10-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C2827734:1+ [Quantitative Concept]
   804   C2981698:1+ [Classification]

Phrase: "M ("

Phrase: "Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.78: However, insulin inhibition of peroxisomal oxidation was more sensitive with a IC50 of 8.5 x 10-11 M. 

Phrase: "However,"

Phrase: "insulin inhibition of peroxisomal oxidation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "was"

Phrase: "more sensitive with a IC50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332324:Sensitive [Functional Concept]
   760   C1550474:sensitive [Idea or Concept]

Phrase: "of 8.5 x 10-11 M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.79: Peroxisomal oxidation was inhibited by 36%, which represents a 22% decrease of the total fatty acid oxidation. 

Phrase: "Peroxisomal oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "inhibited by 36%,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "which"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a 22% decrease of the total fatty acid oxidation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.80: Thus, both peroxisomal and mitochondrial oxidation were affected by insulin. 

Phrase: "Thus,"

Phrase: "both peroxisomal"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C3546463:peroxisomal [Cell Component]
   928 E C0752063:Peroxisomes [Cell Component]
   928 E C2984308:Peroxisome [Functional Concept]

Phrase: "and"

Phrase: "mitochondrial oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "were"

Phrase: "affected by insulin."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C0001721:Affect [Mental Process]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.81: Insulin had no effect of on the oxidation of octanoic acid (Fig. 1, middle panel), which does not require carnitine for metabolism by mitochondria and is not metabolized in peroxisomes. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "had"

Phrase: "no effect of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C1301751:No effect [Qualitative Concept]
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on the oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "of octanoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054616:octanoic acid [Lipid,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "carnitine for metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C1156924:carnitine metabolism [Molecular Function]
   790   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "by mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "and"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "metabolized in peroxisomes."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0752063:Peroxisomes [Cell Component]
   790   C1524026:Metabolized [Cell Function]
   756 E C2984308:Peroxisome [Functional Concept]
   706 E C3546463:peroxisomal [Cell Component]
Processing 00000000.tx.82: View larger version (11K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.83: The effect of insulin on [14C-1] fatty acid oxidation in hepatocytes. 

Phrase: "The effect of insulin on [14C-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "] fatty acid oxidation in hepatocytes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1158366:fatty acid oxidation [Molecular Function]
   806   C0015684:Fatty acid [Lipid]
   760   C0001128:Acid [Chemical]
   760   C0030011:Oxidation [Molecular Function]
   760   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.84: The graphs show the amount of fatty acid oxidized to CO2 (relative to the maximal oxidation for each preparation) at various insulin concentrations. 

Phrase: "The graphs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0681493:graphs [Intellectual Product]
   966 E C2698021:Graph [Conceptual Entity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the amount of fatty acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "oxidized to CO2 ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2347816:Co2+ [Element, Ion, or Isotope]
   756   C0030011:oxidize [Molecular Function]

Phrase: "relative to the maximal oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "for each preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: ")"

Phrase: "at various insulin concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.85: The activities at various insulin concentrations were compared with that at 10-13 M insulin and those statistically significantly different are indicated (*, P < 0.05; ***, P < 0.001). 

Phrase: "The activities at various insulin concentrations"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C1145751:insulin activity [Molecular Function]
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "compared with that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "at 10-13 M insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "those statistically significantly different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705242:Different [Qualitative Concept]
   755 E C1705241:*Difference [Quantitative Concept]
   727 E C0443199:Differential [Qualitative Concept]

Phrase: "are"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "("

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.86: Upper panel, The points represent the means  SEM of at least six independent experiments with palmitic acid (C16:0). 

Phrase: "Upper panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "The points"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552961:Point [Quantitative Concept]
   966   C2347617:point [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the means  SEM of"

Phrase: "at least six independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "with palmitic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030234:Palmitic Acid [Biologically Active Substance,Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(C16"

Phrase: ":"

Phrase: "0"

Phrase: ")."
Processing 00000000.tx.87: The means were curve fit to a one site competition and are shown for total (solid line, r2=0.996) and peroxisomal (dashed line, r2=0.992) oxidation. 

Phrase: "The means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "were"

Phrase: "curve fit to a one site competition"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0036572:Fit [Sign or Symptom]
   748   C0205134:Curve [Spatial Concept]
   748   C0205145:Site [Spatial Concept]
   748   C0205447:One [Quantitative Concept]
   748   C0424576:Fit [Finding]
   748   C0679932:competition [Social Behavior]
   748   C1515974:Site [Body Location or Region]
   748   C2349186:Fit [Activity]
   748   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "are"

Phrase: "shown for total"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439175:% total [Quantitative Concept]
   790   C0439810:Total [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "(solid line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "r2"

Phrase: "=0.996"

Phrase: ")"

Phrase: "and"

Phrase: "peroxisomal"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C3546463:peroxisomal [Cell Component]
   928 E C0752063:Peroxisomes [Cell Component]
   928 E C2984308:Peroxisome [Functional Concept]

Phrase: "(dashed line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "r2"

Phrase: "=0.992"

Phrase: ")"

Phrase: "oxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.88: Middle panel, The points represent the means  SEM of at least four independent experiments with octanoic acid (C8:0). 

Phrase: "Middle panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "The points"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552961:Point [Quantitative Concept]
   966   C2347617:point [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the means  SEM of"

Phrase: "at least four independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "with octanoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054616:octanoic acid [Lipid,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(C8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1305854:C8 [Body Location or Region]

Phrase: ":"

Phrase: "0"

Phrase: ")."
Processing 00000000.tx.89: Lower panel, The points represent the means  SEM of at least four independent experiments with arachidonic acid (C20:4). 

Phrase: "Lower panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "The points"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552961:Point [Quantitative Concept]
   966   C2347617:point [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the means  SEM of"

Phrase: "at least four independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "with arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(C20"

Phrase: ":"

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.90: The means were curve fit to a one site competition and are shown for total (solid line, r2=0.995) and peroxisomal (dashed line, r2=0.997) oxidation.  

Phrase: "The means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "were"

Phrase: "curve fit to a one site competition"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0036572:Fit [Sign or Symptom]
   748   C0205134:Curve [Spatial Concept]
   748   C0205145:Site [Spatial Concept]
   748   C0205447:One [Quantitative Concept]
   748   C0424576:Fit [Finding]
   748   C0679932:competition [Social Behavior]
   748   C1515974:Site [Body Location or Region]
   748   C2349186:Fit [Activity]
   748   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "are"

Phrase: "shown for total"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439175:% total [Quantitative Concept]
   790   C0439810:Total [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "(solid line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "r2"

Phrase: "=0.995"

Phrase: ")"

Phrase: "and"

Phrase: "peroxisomal"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C3546463:peroxisomal [Cell Component]
   928 E C0752063:Peroxisomes [Cell Component]
   928 E C2984308:Peroxisome [Functional Concept]

Phrase: "(dashed line,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "r2"

Phrase: "=0.997"

Phrase: ")"

Phrase: "oxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.91: We also examined the effect of insulin on oxidation of a polyunsaturated fatty acid. 

Phrase: "We also"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "of a polyunsaturated fatty acid."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032615:Polyunsaturated fatty acid [Biologically Active Substance,Lipid]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.92: Total oxidation of arachidonic acid to CO2 was inhibited by insulin in a dose-dependent manner by about 60% at the maximum concentration tested, 10-7 M, with an apparent IC50 of 1.3 x 10-9 M (Fig. 1, lower panel), 10-fold less than that for palmitate. 

Phrase: "Total oxidation of arachidonic acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030011:Oxidation [Molecular Function]

Phrase: "to CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "inhibited by insulin"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in a dose-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "by about 60%"

Phrase: "at the maximum concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C2347813:Maximum Concentration [Quantitative Concept]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "10-7 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "with an apparent IC50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600495:IC50 [Quantitative Concept]

Phrase: "of 1.3 x 10-9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C2827734:1+ [Quantitative Concept]
   804   C2981698:1+ [Classification]

Phrase: "M ("

Phrase: "Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "10-fold less than that"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332462:Fold [Spatial Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "for palmitate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]
Processing 00000000.tx.93: Arachidonic acid oxidation in peroxisomes was somewhat affected, and at a similar concentration (IC50 of 2.5 x 10-9 M). 

Phrase: "Arachidonic acid oxidation in peroxisomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "somewhat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2984079:Somewhat [Intellectual Product]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: ","

Phrase: "and at a similar concentration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C2348205:Similar [Qualitative Concept]

Phrase: "(IC50 of 2.5 x 10-9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0600495:IC50 [Quantitative Concept]

Phrase: "M)."
Processing 00000000.tx.94: The reasons for the quantitative differences compared with palmitate are not clear but may be related to the relative concentrations of endogenous fatty acids or alternative metabolic pathways (e.g. cyclooxygenase). 

Phrase: "The reasons for the quantitative differences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392360:reasons [Idea or Concept]

Phrase: "compared with palmitate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0030233:palmitate [Lipid]
   790   C1707455:Compared [Activity]
   790   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "but"

Phrase: "may"

Phrase: "be"

Phrase: "related to the relative concentrations of endogenous fatty acids"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   764   C0015684:Fatty Acids [Lipid]
   742   C0001128:Acids [Chemical]
   742   C0080103:Relative [Family Group]
   742   C0086045:Concentrations [Mental Process]
   742   C0205227:Endogenous [Functional Concept]
   742   C0205345:Relative [Qualitative Concept]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C1547039:*Relative [Quantitative Concept]
   708 E C0163712:Relate [Organic Chemical]
   708 E C0202406:Acid [Laboratory Procedure]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: "or"

Phrase: "alternative metabolic pathways"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1291081:Metabolic Pathways [Functional Concept]
   827   C0311400:Metabolic [Functional Concept]
   827   C1524026:Metabolic [Cell Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
   827   C2707259:Metabolic [Clinical Attribute]

Phrase: "("

Phrase: "e.g. cyclooxygenase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033551:Cyclo-Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0389003:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1565860:Cyclooxygenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.95: To examine possible mechanisms of insulin inhibition of peroxisomal fatty acid oxidation, we prepared purified peroxisomes for additional studies (Table 1). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "possible mechanisms of insulin inhibition of peroxisomal fatty acid oxidation,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0441712:Mechanisms [Functional Concept]
   706 E C1706376:Mechanism [Manufactured Object]

Phrase: "we"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "purified peroxisomes for additional studies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0752063:Peroxisomes [Cell Component]
   726 E C2984308:Peroxisome [Functional Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.96: Peroxisomal markers were enriched about 10-fold, which is similar to previous studies. 

Phrase: "Peroxisomal markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "were"

Phrase: "enriched about 10-fold,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332462:Fold [Spatial Concept]
   770   C0359583:enriched [Food]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: "which"

Phrase: "is"

Phrase: "similar to previous studies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.97: Insulin degrading enzyme has a type-1 peroxisomal targeting sequence and has been reported to be present in this organelle. 

Phrase: "Insulin degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "a type-1 peroxisomal targeting sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0004793:Sequence [Nucleotide Sequence]
   804   C0162326:Sequence [Nucleotide Sequence]
   804   C0162327:Sequence [Nucleotide Sequence]
   804   C1519249:Sequence [Functional Concept]
   733 E C1548958:Sequential [Idea or Concept]
   733 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present in this organelle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
Processing 00000000.tx.98: A Western blot with 9B12 anti-IDE antibody (Fig. 2) confirms its presence in peroxisomes. 

Phrase: "A Western blot with 9B12 anti-IDE antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0949466:Western Blot [Laboratory Procedure]
   739   C1705493:Western [Spatial Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "its presence in peroxisomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.99: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.100: Enrichment of organelle marker enzymes in purified liver peroxisomes  View larger version (25K): [in this window] [in a new window]  Figure 2. 

Phrase: "Enrichment of organelle marker enzymes"

Phrase: "in purified liver peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0752063:Peroxisomes [Cell Component]
   793 E C2984308:Peroxisome [Functional Concept]
   743 E C3546463:peroxisomal [Cell Component]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.101: Anti-IDE Western blot of Percoll purified peroxisomes. 

Phrase: "Anti-IDE Western blot of Percoll purified peroxisomes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0949466:Western Blot [Laboratory Procedure]
   739   C1705493:Western [Spatial Concept]
Processing 00000000.tx.102: Peroxisomal proteins were run on SDS-PAGE and a Western blot analysis performed with 9B12 antibody. 

Phrase: "Peroxisomal proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "run on SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   812   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "a Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "performed with 9B12 antibody."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.103: A band is present at 110 kDa, the known molecular mass of insulin degrading enzyme.  

Phrase: "A band"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0230715:A band [Cell Component]
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "is"

Phrase: "present at 110 kDa,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "the known molecular mass of insulin degrading enzyme."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   744   C0577559:Mass [Finding]
   744   C1306372:*Mass [Quantitative Concept]
Processing 00000000.tx.104: Peroxisomal function was assessed by measuring O2 consumption, which reflects overall lipid -oxidation. 

Phrase: "Peroxisomal function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "was"

Phrase: "assessed by measuring O2 consumption,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0009830:Consumption [Activity]
   760   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0444706:measuring [Qualitative Concept]
   760   C0449770:measuring [Quantitative Concept]
   760   C1516048:Assessed [Activity]
   760   C1947907:Consumption [Physiologic Function]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "which"

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "overall lipid -oxidation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2612546:lipid oxidation [Molecular Function]
   827   C0023779:Lipid [Lipid]
   827   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.105: The addition of insulin to purified peroxisomes reduced O2 consumption, indicating inhibition of lipid oxidation (Fig. 3). 

Phrase: "The addition of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "to purified peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0752063:Peroxisomes [Cell Component]
   827 E C2984308:Peroxisome [Functional Concept]
   777 E C3546463:peroxisomal [Cell Component]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "O2 consumption,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0009830:Consumption [Activity]
   861   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1947907:Consumption [Physiologic Function]

Phrase: "indicating"

Phrase: "inhibition of lipid oxidation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.106: Insulin also inhibited peroxisomal AOX and FAOS activities but not catalase (Fig. 4). 

Phrase: "Insulin also"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "peroxisomal AOX"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0541394:peroxisomal acyl-CoA oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0050690:acyl-CoA oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1412128:ACYL-CoA OXIDASE [Gene or Genome]
   923   C2984960:Acyl CoA Oxidase [Laboratory Procedure]
   902   C0443562:Peroxisomal oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001374:Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "FAOS activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   799   C0441655:Activities [Activity]
   766 E C0205177:Activity [Functional Concept]
   766 E C0439167:% activity [Quantitative Concept]
   766 E C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "not catalase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1413138:CATALASE [Gene or Genome]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.107: This selectivity of effect on enzymatic activities indicates that insulin does not have a general, nonspecific action on peroxisomal enzymes. 

Phrase: "This selectivity of effect"

Phrase: "on enzymatic activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C2267219:Enzymatic Activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "indicates"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "a general, nonspecific action on peroxisomal enzymes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441472:Action [Functional Concept]
   748   C3266814:Action [Activity]
Processing 00000000.tx.108: View larger version (20K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.109: Insulin inhibits O2 consumption by purified liver peroxisomes. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "O2 consumption by purified liver peroxisomes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0009830:Consumption [Activity]
   753   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1947907:Consumption [Physiologic Function]
Processing 00000000.tx.110: Basal O2 consumption levels by Percoll-purified liver peroxisomes were established, then palmitoyl CoA was added where indicated. 

Phrase: "Basal O2 consumption levels by Percoll-purified liver peroxisomes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: ","

Phrase: "then palmitoyl CoA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0030239:Palmitoyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "where"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.111: After a steady rate of O2 consumption was established, insulin (1 M) was added where indicated. 

Phrase: "After a steady rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "of O2 consumption"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0009830:Consumption [Activity]
   861   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1947907:Consumption [Physiologic Function]

Phrase: "was"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: ","

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "M)"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "where"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.112: Data are expressed as nmol oxygen present in the chamber vs. time (minutes). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as nmol oxygen present"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0150312:Present [Quantitative Concept]
   760   C0439191:NMOLE [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "in the chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "vs. time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "(minutes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439232:minute [Temporal Concept]
  1000   C0700321:minute [Quantitative Concept]
  1000   C0702093:/minute [Temporal Concept]
  1000   C1282918:Minute [Quantitative Concept]
  1000   C2347166:Minute [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.113: Rates were calculated from the slopes observed.  

Phrase: "Rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0871208:Rate [Activity]
   966   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "calculated from the slopes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444686:Calculated [Functional Concept]
   770   C0807955:slopes [Quantitative Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.114: View larger version (16K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.115: The effect of insulin on peroxisomal fatty acid oxidizing activities. 

Phrase: "The effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on peroxisomal fatty acid oxidizing activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0441655:Activities [Activity]
   771 E C0205177:Activity [Functional Concept]
   771 E C0439167:% activity [Quantitative Concept]
   771 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.116: Fatty acid oxidation by Percoll-purified liver peroxisomes was measured by AOX (n = 7), FAOS (n = 8), and O2 consumption (n = 5) in the presence and absence of 1 M insulin. 

Phrase: "Fatty acid oxidation by Percoll-purified liver peroxisomes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C1158366:fatty acid oxidation [Molecular Function]
   770   C0015684:Fatty acid [Lipid]
   767   C0015695:Fatty Liver [Disease or Syndrome]
   744   C0001128:Acid [Chemical]
   744   C0030011:Oxidation [Molecular Function]
   744   C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "measured by AOX"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   862   C0050690:acyl-CoA oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1412128:ACYL-CoA OXIDASE [Gene or Genome]
   862   C2984960:Acyl CoA Oxidase [Laboratory Procedure]
   806   C0001374:Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0444706:Measured [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "(n = 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "FAOS"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]
   717   C0001374:Fatty Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "O2 consumption"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0009830:Consumption [Activity]
   861   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1947907:Consumption [Physiologic Function]

Phrase: "(n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "absence of 1 M insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.117: As a control, the insulin effect on catalase activity was also determined (n = 5). 

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the insulin effect on catalase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "determined"

Phrase: "(n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.118: Data are expressed as % of enzyme activity with addition of vehicle only. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as % of enzyme activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0243102:enzyme activity [Molecular Function]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "with addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of vehicle only."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0042444:Vehicle [Biomedical or Dental Material]
   861   C0348005:Vehicle [Manufactured Object]
   789 E C0445373:Vehicular [Functional Concept]
Processing 00000000.tx.119: *, P < 0.05; 

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.120: ** P < 0.005 compared by t test with the insulin effect on catalase.  

Phrase: "*"

Phrase: "* P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared by t test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]
   770   C1707455:Compared [Activity]

Phrase: "with the insulin effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "on catalase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]
Processing 00000000.tx.121: To examine a potential role for IDE in mediating the insulin effect on peroxisomes, an anti-IDE monoclonal antibody that inhibits insulin degradation was added to these organelles and the effect of insulin assessed (Fig. 5). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "a potential role for IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "the insulin effect on peroxisomes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "an anti-IDE monoclonal antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   904   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   895   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C0746619:monoclonal [Finding]

Phrase: "that"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "added to these organelles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0029219:Organelles [Cell Component]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.122: The antibody increased basal FAOS activity slightly and blocked the inhibitory effect of insulin on FAOS activity. 

Phrase: "The antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "basal FAOS activity slightly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0205177:Activity [Functional Concept]
   793   C0439167:% activity [Quantitative Concept]
   793   C0441655:Activity [Activity]
   793   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the inhibitory effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on FAOS activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.123: A similar experiment was done for catalase and showed no effect of the antibody on enzyme activity (data not shown). 

Phrase: "A similar experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "done for catalase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1272695:Done [Qualitative Concept]
   790   C1413138:CATALASE [Gene or Genome]
   790   C2746065:Done [Temporal Concept]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no effect of the antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on enzyme activity"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0243102:enzyme activity [Molecular Function]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.124: View larger version (16K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.125: Anti-IDE antibody blocks the insulin inhibition of peroxisomal FAOS. 

Phrase: "Anti-IDE antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the insulin inhibition of peroxisomal FAOS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3463820:Inhibition [Activity]
Processing 00000000.tx.126: The FAOS activity in purified liver peroxisomes was measured in the presence and absence of anti-IDE antibody C203.1A with (filled bars) and without (open bars) 1 M insulin. 

Phrase: "The FAOS activity in purified liver peroxisomes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured in the presence"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "absence of anti-IDE antibody C203.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332197:absence [Quantitative Concept]
   742   C1689985:Absence [Anatomical Abnormality]

Phrase: "with"

Phrase: "(filled bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "and without"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "(open bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "1 M insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.127: Data are expressed as % FAOS activity compared by t test with addition of vehicle only. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed"

Phrase: "as % FAOS activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]

Phrase: "compared by t test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]
   770   C1707455:Compared [Activity]

Phrase: "with addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of vehicle only."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0042444:Vehicle [Biomedical or Dental Material]
   861   C0348005:Vehicle [Manufactured Object]
   789 E C0445373:Vehicular [Functional Concept]
Processing 00000000.tx.128: *, P < 0.05; 

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.129: n = 3.   

Phrase: "n = 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.130: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  Insulin exerts control over a wide variety of cellular functions, including glucose, protein, and lipid metabolism. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "control over a wide variety of cellular functions,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   750   C2587213:Control function [Functional Concept]
           Control
   744   C0243148:control [Qualitative Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C3274648:Control [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "lipid metabolism."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598783:Lipid Metabolism [Molecular Function]
  1000   C1517898:Lipid Metabolism [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.131: Although attention has focused on glucose turnover, the primary metabolic derangement associated with type 2 diabetes may pertain as much to alterations in lipid metabolism as to glucose control (1, 2, 29, 30). 

Phrase: "Although"

Phrase: "attention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004268:Attention [Mental Process]

Phrase: "has"

Phrase: "focused on glucose turnover,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0031227:turnover [Quantitative Concept]
   770   C0205234:Focused [Spatial Concept]
   770   C0243127:turnover [Functional Concept]
   770   C0443331:Turnover [Health Care Activity]
   770   C1285542:focused [Functional Concept]

Phrase: "the primary metabolic derangement"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "may"

Phrase: "pertain as much"

Phrase: "to alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515926:Alteration [Idea or Concept]

Phrase: "in lipid metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598783:Lipid Metabolism [Molecular Function]
  1000   C1517898:Lipid Metabolism [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "as to glucose control"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0726398:GLUCOSE CONTROL [Indicator, Reagent, or Diagnostic Aid]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.132: One effect of insulin is to decrease fatty acid oxidation. 

Phrase: "One effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "fatty acid oxidation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.133: It does this in part by decreasing triglyceride breakdown, thereby decreasing substrate availability and increasing glucose metabolism. 

Phrase: "It"

Phrase: "does"

Phrase: "this in part"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1080058:This [Eukaryote]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by decreasing triglyceride breakdown,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1157922:triglyceride breakdown [Molecular Function]
   827   C0443161:break down [Qualitative Concept]
   827   C0699900:breakdown [Organism Function]
   827   C1265875:breakdown [Acquired Abnormality]

Phrase: "thereby"

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "substrate availability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470187:Availability [Functional Concept]

Phrase: "and"

Phrase: "increasing glucose metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0596620:glucose metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.134: The increased glucose metabolism results in an increase in malonyl CoA, an inhibitor of CPT I, which is required for long chain fatty acid oxidation by mitochondria (10, 11, 12, 13). 

Phrase: "The increased glucose metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0596620:glucose metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0860803:increased glucose [Finding]

Phrase: "results in an increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442805:Increase [Functional Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "in malonyl CoA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024645:Malonyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "an inhibitor of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999216:Inhibitor [Qualitative Concept]

Phrase: "CPT I,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0085966:Carnitine Palmitoyltransferase I [Amino Acid, Peptide, or Protein,Enzyme]
   882   C2258044:carnitine palmitoyltransferase I [Molecular Function]
   833   C0007262:Carnitine Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0729572:Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0021966:I- [Inorganic Chemical]
   753   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "which"

Phrase: "is"

Phrase: "required for long chain fatty acid oxidation"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   853   C0522095:Long chain fatty acid [Biologically Active Substance,Lipid]
   814   C1158366:fatty acid oxidation [Molecular Function]
   778   C0015684:Fatty acid [Lipid]
   748   C0001128:Acid [Chemical]
   748   C0030011:Oxidation [Molecular Function]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0205166:Long [Qualitative Concept]
   748   C0337112:Chain [Manufactured Object]
   748   C1514873:Required [Functional Concept]
   748   C1524075:Chain [Idea or Concept]
   748   C1706317:Long [Qualitative Concept]

Phrase: "by mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "(10,"

Phrase: "11,"

Phrase: "12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.135: However, long and especially very long chain fatty acids are also metabolized by peroxisomes (14). 

Phrase: "However,"

Phrase: "long"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "especially very long chain fatty acids"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   947   C0443566:very long chain fatty acids [Laboratory Procedure]
   914 E C0542549:Very long chain fatty acid [Lipid]
   867   C0522095:Long chain fatty acid [Biologically Active Substance,Lipid]
   861   C1980013:Very long chain [Qualitative Concept]
   827   C0015684:Fatty Acids [Lipid]
   799   C0001128:Acids [Chemical]
   799   C0205166:Long [Qualitative Concept]
   799   C0337112:Chain [Manufactured Object]
   799   C0442824:Very [Qualitative Concept]
   799   C1524075:Chain [Idea or Concept]
   799   C1706317:Long [Qualitative Concept]
   766 E C0202406:Acid [Laboratory Procedure]

Phrase: "are"

Phrase: "also"

Phrase: "metabolized by peroxisomes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0752063:Peroxisomes [Cell Component]
   790   C1524026:Metabolized [Cell Function]
   756 E C2984308:Peroxisome [Functional Concept]
   706 E C3546463:peroxisomal [Cell Component]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.136: Our results show that peroxisomal fatty acid oxidation is inhibited at a much lower insulin concentration than is mitochondrial oxidation. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that peroxisomal fatty acid oxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1158366:fatty acid oxidation [Molecular Function]
   861   C0015684:Fatty acid [Lipid]
   812   C0001128:Acid [Chemical]
   812   C0030011:Oxidation [Molecular Function]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "is"

Phrase: "inhibited at a much lower insulin concentration"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0086045:Concentration [Mental Process]
   748   C0311403:Inhibited [Qualitative Concept]
   748   C0441994:Lower [Spatial Concept]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1548802:Lower [Body Location or Region]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2003888:Lower [Activity]

Phrase: "than"

Phrase: "is"

Phrase: "mitochondrial oxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.137: This suggests a different mechanism for control of peroxisomal fatty acid oxidation. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a different mechanism for control of peroxisomal fatty acid oxidation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0441712:Mechanism [Functional Concept]
   739   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.138: The oxidation of octanoic acid does not require the action of CPT I for its transport into the matrix. 

Phrase: "The oxidation of octanoic acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030011:Oxidation [Molecular Function]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "the action of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0441472:Action [Functional Concept]
   790   C3266814:Action [Activity]

Phrase: "CPT I"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0085966:Carnitine Palmitoyltransferase I [Amino Acid, Peptide, or Protein,Enzyme]
   882   C2258044:carnitine palmitoyltransferase I [Molecular Function]
   833   C0007262:Carnitine Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0729572:Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0021966:I- [Inorganic Chemical]
   753   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "for its transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "into the matrix."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704640:Matrix [Spatial Concept]
  1000   C1706515:Matrix [Body Substance]
Processing 00000000.tx.139: In our studies octanoic acid metabolism was unaffected by insulin. 

Phrase: "In our studies octanoic acid metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0025519:Metabolism [Organism Function]
   812   C0025520:metabolism [Functional Concept]

Phrase: "was"

Phrase: "unaffected by insulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.140: Thus, mitochondrial function per se was not altered by insulin. 

Phrase: "Thus,"

Phrase: "mitochondrial function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "per se"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered by insulin."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0392747:Altered [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.141: Palmitate oxidation, however, was affected in both mitochondria and peroxisomes. 

Phrase: "Palmitate oxidation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "however,"

Phrase: "was"

Phrase: "affected in both mitochondria"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0026237:Mitochondria [Cell Component]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]

Phrase: "and"

Phrase: "peroxisomes."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]
Processing 00000000.tx.142: Peroxisomal oxidation was much more sensitive to insulin, by a factor of 150, indicating that it was not working by the same mechanism in the two different organelles. 

Phrase: "Peroxisomal oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "much more sensitive to insulin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "by a factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "of 150,"

Phrase: "indicating"

Phrase: "that"

Phrase: "it"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "working by the same mechanism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0043227:Working [Occupational Activity]
   760   C0441712:Mechanism [Functional Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "in the two different organelles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0029219:Organelles [Cell Component]
Processing 00000000.tx.143: The mitochondrial inhibition was probably primarily mediated by malonyl CoA inhibition of CPT I. 

Phrase: "The mitochondrial inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "was"

Phrase: "probably primarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750492:Probably [Idea or Concept]

Phrase: "mediated by malonyl CoA inhibition of"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0024645:Malonyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "CPT I."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0085966:Carnitine Palmitoyltransferase I [Amino Acid, Peptide, or Protein,Enzyme]
   882   C2258044:carnitine palmitoyltransferase I [Molecular Function]
   833   C0007262:Carnitine Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0729572:Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0021966:I- [Inorganic Chemical]
   753   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.144: Arachidonic acid metabolism was affected by insulin, but the effect was primarily on mitochondrial oxidation with a smaller effect on peroxisomal oxidation, and with different IC50s than for palmitate. 

Phrase: "Arachidonic acid metabolism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1158360:arachidonic acid metabolism [Molecular Function]
  1000   C1879725:Arachidonic Acid Metabolism [Molecular Function]
   913   C0596480:arachidonic metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0003695:Arachidonic Acid [Eicosanoid]
   734   C2316832:Arachidonic Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "affected by insulin,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C0001721:Affect [Mental Process]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "but"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "primarily on mitochondrial oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026237:Mitochondrial [Cell Component]
   770   C0030011:Oxidation [Molecular Function]
   770   C0521451:Mitochondrial [Functional Concept]

Phrase: "with a smaller effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "on peroxisomal oxidation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "and with different IC50s"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1515981:And [Idea or Concept]
   770   C1705242:Different [Qualitative Concept]
   737   C0600495:IC50 [Quantitative Concept]

Phrase: "than"

Phrase: "for palmitate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030233:palmitate [Lipid]
  1000   C3503116:palmitate [Biomedical or Dental Material,Lipid]
Processing 00000000.tx.145: Insulin degrading enzyme (IDE) has a type-1 peroxisomal targeting sequence (31, 32, 33), and some data suggest that it may be concentrated in these organelles (34). 

Phrase: "Insulin degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "has"

Phrase: "a type-1 peroxisomal targeting sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0004793:Sequence [Nucleotide Sequence]
   804   C0162326:Sequence [Nucleotide Sequence]
   804   C0162327:Sequence [Nucleotide Sequence]
   804   C1519249:Sequence [Functional Concept]
   733 E C1548958:Sequential [Idea or Concept]
   733 E C1705294:Sequential [Qualitative Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32,"

Phrase: "33"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "some data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "concentrated in these organelles"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0029219:Organelles [Cell Component]
   770   C1880165:Concentrated [Biomedical or Dental Material]
   737 E C1880310:Concentrate [Manufactured Object]
   737 E C2003864:Concentrate [Substance]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.146: A Western blot (Fig. 2) demonstrates its presence in our preparations. 

Phrase: "A Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "demonstrates"

Phrase: "its presence in our preparations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.147: Furthermore, our data show IDE has a role in modulating peroxisomal enzyme activity. 

Phrase: "Furthermore,"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "a role in modulating peroxisomal enzyme activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.148: Insulin incubated with purified peroxisomes inhibited fatty oxidation and lowered O2 consumption. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "incubated with purified peroxisomes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0752063:Peroxisomes [Cell Component]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1998793:Purified [Functional Concept]
   737 E C2984308:Peroxisome [Functional Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "fatty oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "and"

Phrase: "lowered O2 consumption."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0009830:Consumption [Activity]
   827   C0030054:O2 [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1947907:Consumption [Physiologic Function]
Processing 00000000.tx.149: An inhibitory anti-IDE antibody abolished the insulin effect. 

Phrase: "An inhibitory anti-IDE antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   885   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   876   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "abolished"

Phrase: "the insulin effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.150: Thus, enzymatically active IDE is required for the effect. 

Phrase: "Thus,"

Phrase: "enzymatically active IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "required for the effect."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1280500:Effect [Qualitative Concept]
   770   C1514873:Required [Functional Concept]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.151: Whether the enzyme is involved directly or whether insulin degradation products are required is still to be determined. 

Phrase: "Whether"

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "or"

Phrase: "whether"

Phrase: "insulin degradation products"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0021641:insulin products [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]
   734   C3547574:insulin degradation [Molecular Function]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "is"

Phrase: "still to"

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.152: However, this function of IDE is similar to one we have described for its interaction with the proteasome (27, 28, 35, 36, 37). 

Phrase: "However,"

Phrase: "this function of IDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "similar to one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205447:One [Quantitative Concept]

Phrase: "we"

Phrase: "have"

Phrase: "described for its interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C1704675:Interaction [Functional Concept]

Phrase: "with the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "(27,"

Phrase: "28,"

Phrase: "35,"

Phrase: "36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.153: In that system, insulin, binding to IDE, inhibited two peptidolytic activities of the proteasome. 

Phrase: "In"

Phrase: "that system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "binding to IDE,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   797   C1149286:enzyme binding [Molecular Function]
   797   C1623517:insulin binding [Molecular Function]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "two peptidolytic activities of the proteasome."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C1622946:proteasome activity [Molecular Function]
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.154: This results in a typical insulin action, a decrease in cellular protein degradation. 

Phrase: "This results in a typical insulin action,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "a decrease in cellular protein degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.155: A similar situation is found with IDE and interactions with the androgen and glucocorticoid receptors (38, 39). 

Phrase: "A similar situation"

Phrase: "is"

Phrase: "found with IDE"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0150312:Found [Quantitative Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C0243095:Find [Finding]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "interactions with the androgen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "glucocorticoid receptors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   966 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017710:Glucocorticoid [Hormone,Steroid]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.156: In the current system, another typical insulin action, decreased fatty acid oxidation, is also achieved by insulin interacting with IDE in association with a subcellular organelle. 

Phrase: "In the current system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "another typical insulin action,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441472:Action [Functional Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C3266814:Action [Activity]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "fatty acid oxidation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "is"

Phrase: "also"

Phrase: "achieved by insulin interacting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "with IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with a subcellular organelle."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029219:Organelle [Cell Component]
Processing 00000000.tx.157: We propose that IDE mediates these effects of insulin, acting as an intracellular receptor for the hormone. 

Phrase: "We"

Phrase: "propose"

Phrase: "that IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "these effects of insulin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "acting as an intracellular receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   726   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "for the hormone."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormone [Hormone]
   928 E C0458083:Hormonal [Qualitative Concept]
Processing 00000000.tx.158: This idea is especially interesting in light of the recent identification of IDE as a candidate susceptibility gene in GK rats, a model of type 2 diabetes (40). 

Phrase: "This idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "is"

Phrase: "especially"

Phrase: "interesting in light of the recent identification of IDE"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   775   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   775   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   738   C0014442:Enzyme [Enzyme,Organic Chemical]
   738   C0020792:Identification [Mental Process]
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0023693:Light [Natural Phenomenon or Process]
   738   C0205396:Identification [Qualitative Concept]
   738   C0332185:Recent [Temporal Concept]
   738   C0543488:interesting [Mental Process]
   738   C1306462:Light [Functional Concept]
   738   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1579433:Insulin [Pharmacologic Substance]
   738   C1881376:Light [Qualitative Concept]

Phrase: "as a candidate susceptibility gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1332838:Candidate Gene [Gene or Genome]
   901   C0919453:Susceptibility Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "in GK rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "a model of type 2 diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.159: The exact mechanism remains to be elucidated, but since insulin and the anti-IDE antibodies have effects in permeabilized peroxisomes, IDE apparently does not work by altering fatty acid transport into peroxisomes, but rather has a more direct action. 

Phrase: "The exact mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated"

Phrase: ","

Phrase: "but"

Phrase: "since insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the anti-IDE antibodies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   911   C0021644:anti insulin antibodies [Immunologic Factor]
           Insulin Antibodies
   897   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   881 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "have"

Phrase: "effects in permeabilized peroxisomes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "IDE apparently"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "work by altering fatty acid transport"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0596564:fatty acid transport [Cell Function]
   790   C0015684:Fatty acid [Lipid]
   753   C0001128:Acid [Chemical]
   753   C0005528:Transport, NOS [Cell Function]
   753   C0043227:Work [Occupational Activity]
   753   C0202406:Acid [Laboratory Procedure]
   753   C1317949:Transport [Manufactured Object]
   753   C3495449:transport [Medical Device]

Phrase: "into peroxisomes,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: "but"

Phrase: "rather"

Phrase: "has"

Phrase: "a more direct action."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439851:Direct [Qualitative Concept]
   827   C0441472:Action [Functional Concept]
   827   C1947931:Direct [Qualitative Concept]
   827   C3266814:Action [Activity]
Processing 00000000.tx.160: Fatty acids or their acyl-CoA thioesters are known to be ligands for peroxisome proliferator-activated receptors (PPARs) and other transcription factors and to alter gene expression (41, 42, 43, 44, 45, 46). 

Phrase: "Fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "their acyl-CoA thioesters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0597572:thioester [Organic Chemical]
   734   C0001374:Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "ligands for peroxisome proliferator-activated receptors (PPARs)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0023688:Ligands [Chemical]
   750   C1621296:receptor ligand [Molecular Function]
   716   C0166418:Peroxisome Proliferator-Activated Receptors [Amino Acid, Peptide, or Protein,Receptor]
   704 E C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]

Phrase: "and"

Phrase: "other transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(41,"

Phrase: "42,"

Phrase: "43,"

Phrase: "44,"

Phrase: "45,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.161: Fatty acids or their acyl-CoA thioesters are also known to alter a number of enzyme activities, such as acetyl-CoA carboxylase, tricarboxylate carrier, and mitochondrial uncoupling proteins (UCP) (47, 48). 

Phrase: "Fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "their acyl-CoA thioesters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0597572:thioester [Organic Chemical]
   734   C0001374:Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "also"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "a number of enzyme activities,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "such as acetyl-CoA carboxylase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001022:Acetyl-CoA Carboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0007064:Carboxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "tricarboxylate carrier,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0055817:tricarboxylate carrier [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0007294:Carrier [Finding]
   861   C0560175:Carrier [Finding]
   861   C1706209:Carrier [Medical Device]
   861   C3273162:Carrier [Intellectual Product]

Phrase: "and"

Phrase: "mitochondrial uncoupling proteins (UCP)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0066604:mitochondrial uncoupling protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   913   C0949610:Mitochondrial Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(47,"

Phrase: "48"

Phrase: ")."
Processing 00000000.tx.162: Thus, hormonal control of peroxisomal activity and the subsequent changes in the levels of fatty acids could result in significant alteration in cellular metabolism both short-term (enzyme activity) and long term (gene transcription). 

Phrase: "Thus,"

Phrase: "hormonal control of peroxisomal activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C1706449:Active Control [Research Activity]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "the subsequent changes in the levels of fatty acids"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   745   C0025320:The change [Physiologic Function]
   745   C0152254:Fatty change [Pathologic Function]
   742   C0392747:changes [Functional Concept]
   742   C0443172:changes [Quantitative Concept]
   708 E C1705241:Change [Quantitative Concept]

Phrase: "could"

Phrase: "result in significant alteration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0237881:significant [Quantitative Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1274040:Result [Functional Concept]
   770   C1515926:Alteration [Idea or Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]
   770   C2825142:Result [Finding]

Phrase: "in cellular metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1524026:cellular metabolism [Cell Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "both short-term"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0443303:Short-term [Temporal Concept]
   861   C1282927:short [Qualitative Concept]
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C1806781:Short [Quantitative Concept]
   861   C2350002:Short [Quantitative Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "(enzyme activity"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0243102:enzyme activity [Molecular Function]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
   777 E C0014445:enzymes [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "long term"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0443252:Long-term [Temporal Concept]
   861   C0205166:Long [Qualitative Concept]
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C1706317:Long [Qualitative Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "(gene transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: ")."
Processing 00000000.tx.163: Insulins action in peroxisomes at relatively lower concentrations may be directed at altering the relative composition of available intracellular FFA, rather than altering total cellular fatty acid oxidation. 

Phrase: "Insulins action in peroxisomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441472:Action [Functional Concept]
   770   C3266814:Action [Activity]

Phrase: "at relatively lower concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "may"

Phrase: "be"

Phrase: "directed at altering"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0439851:Direct [Qualitative Concept]
   756   C1947931:Direct [Qualitative Concept]

Phrase: "the relative composition of available intracellular FFA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0486616:Composition [Clinical Attribute]
   748   C1555710:composition [Idea or Concept]

Phrase: "rather than"

Phrase: "altering total cellular fatty acid oxidation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1158366:fatty acid oxidation [Molecular Function]
   799   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.164: These changes in fatty acid composition would work as another signal transduction mechanism of insulin, and one where dietary status could directly affect insulin action. 

Phrase: "These changes in fatty acid composition"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C0152254:Fatty change [Pathologic Function]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "would"

Phrase: "work as another signal transduction mechanism of insulin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0037083:Signal Transduction [Cell Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0043227:Work [Occupational Activity]
   744   C0441712:Mechanism [Functional Concept]
   744   C1160185:transduction [Organism Function]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1706376:Mechanism [Manufactured Object]
   744   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "one where dietary status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392209:Dietary status [Organism Attribute]
   812   C0449438:Status [Qualitative Concept]

Phrase: "could"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "insulin action."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.165: While highly speculative, excessive dietary fatty acids would increase intracellular fatty acid levels and alter their relative composition, overwhelming this subtle control by insulin. 

Phrase: "While"

Phrase: "highly speculative, excessive dietary fatty acids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   844   C2348264:Dietary Fatty Acid [Lipid]
   827   C0015684:Fatty Acids [Lipid]
   799   C0001128:Acids [Chemical]
   766 E C0202406:Acid [Laboratory Procedure]

Phrase: "would"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "intracellular fatty acid levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   890   C1281901:Fatty acid level [Laboratory Procedure]
   861   C0015684:Fatty acid [Lipid]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "their relative composition,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0486616:Composition [Clinical Attribute]
   861   C1555710:composition [Idea or Concept]

Phrase: "overwhelming"

Phrase: "this subtle control by insulin."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.166: These changes could contribute to insulin resistance by altering normal fatty acid-mediated control of the PPARs. 

Phrase: "These changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "could"

Phrase: "contribute to insulin resistance"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   783   C0332325:Resistant to [Functional Concept]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1880177:Contribute [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "by altering normal fatty acid-mediated control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C2705716:normal control [Qualitative Concept]
   799   C0243148:control [Qualitative Concept]
   799   C1550141:Control [Substance]
   799   C1882979:Control [Conceptual Entity]
   799   C2587213:Control [Functional Concept]
   799   C3274648:Control [Qualitative Concept]

Phrase: "of the PPARs."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0166418:Peroxisome Proliferator-Activated Receptors [Amino Acid, Peptide, or Protein,Receptor]
   988 E C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   861   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   812   C0752063:Peroxysome [Cell Component]
   812   C1879547:Activated [Activity]
   812   C2984308:Peroxisome [Functional Concept]
   779 E C1515877:Activate [Functional Concept]
   741 E C3546463:peroxisomal [Cell Component]
Processing 00000000.tx.167: The thiazolidinediones may act to reverse these changes. 

Phrase: "The thiazolidinediones"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1257987:Thiazolidinediones [Organic Chemical,Pharmacologic Substance]
   966 E C0289779:thiazolidinedione [Organic Chemical,Pharmacologic Substance]
   966 E C3537039:Thiazolidinedione [Pharmacologic Substance]

Phrase: "may"

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "these changes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.168: In summary, insulin decreases fatty acid oxidation in peroxisomes. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "fatty acid oxidation in peroxisomes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1158366:fatty acid oxidation [Molecular Function]
   806   C0015684:Fatty acid [Lipid]
   760   C0001128:Acid [Chemical]
   760   C0030011:Oxidation [Molecular Function]
   760   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.169: This action requires insulin degrading enzyme and thus uses a mechanism distinct from the one that decreases fatty acid oxidation in mitochondria in response to insulin; 

Phrase: "This action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]

Phrase: "requires"

Phrase: "insulin degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "thus"

Phrase: "uses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "distinct from the one"

Phrase: "that"

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "fatty acid oxidation in mitochondria"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1158366:fatty acid oxidation [Molecular Function]
   806   C0015684:Fatty acid [Lipid]
   760   C0001128:Acid [Chemical]
   760   C0030011:Oxidation [Molecular Function]
   760   C0202406:Acid [Laboratory Procedure]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.170: malonyl CoA inhibition of CPT I. 

Phrase: "malonyl CoA inhibition of"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "CPT I."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0085966:Carnitine Palmitoyltransferase I [Amino Acid, Peptide, or Protein,Enzyme]
   882   C2258044:carnitine palmitoyltransferase I [Molecular Function]
   833   C0007262:Carnitine Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0729572:Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0021966:I- [Inorganic Chemical]
   753   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.171: While the effect of insulin in peroxisomes on total fatty acid oxidation by the cell is relatively minor, the resulting change in the fatty acid composition available for metabolism and regulatory control would provide an additional mechanism for insulin-directed regulation of cellular activities.  

Phrase: "While"

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "in peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: "on total fatty acid oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1158366:fatty acid oxidation [Molecular Function]
   812   C0030011:Oxidation [Molecular Function]

Phrase: "by the cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "relatively minor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026193:Minor [Population Group]
   861   C0205165:Minor [Qualitative Concept]

Phrase: "the resulting change in the fatty acid composition"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0025320:The change [Physiologic Function]
   767   C0152254:Fatty change [Pathologic Function]
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: "available for metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: "and"

Phrase: "regulatory control"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0220905:regulatory [Regulation or Law]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1704735:Regulatory [Conceptual Entity]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "would"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an additional mechanism for insulin-directed regulation of cellular activities."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0441712:Mechanism [Functional Concept]
   739   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.172: Acknowledgments  The authors thank Jennifer L. 

Phrase: "Acknowledgments"

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Jennifer L."
Processing 00000000.tx.173: Larsen for critical reading of the manuscript.  

Phrase: "Larsen for critical reading of the manuscript."
Processing 00000000.tx.174: Footnotes  1 This work supported by the Medical Research Service of the Department of Veterans Affairs and the Bly Memorial Research Fund, University of Nebraska Medical Center. 

Phrase: "Footnotes  1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2825232:Footnote [Intellectual Product]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "supported by the Medical Research Service of the Department of Veterans Affairs"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   790   C3496098:Department of Veterans Affairs [Health Care Related Organization]
   755   C1568415:Support of Research [Intellectual Product]
   753   C0079816:Medical Research [Research Activity]
   753   C1549054:Veterans Affairs [Organization]
   753   C1556038:Medical Research [Professional or Occupational Group]
   751   C0035176:research supported [Quantitative Concept]
   751   C0199168:Medical service [Health Care Activity]
   751   C0587450:Medical department [Health Care Related Organization]
   751   C0587569:medical service [Health Care Activity]
   751   C1546531:Medical Service [Health Care Related Organization]
   736   C0035168:research [Research Activity]
   736   C0042610:Veterans [Population Group]
   736   C0205476:Medical [Functional Concept]
   736   C0242481:Research [Research Activity]
   736   C0557854:Service [Occupational Activity]
   736   C1521721:Supported [Conceptual Entity]
   736   C1704729:Department [Organization]
   736   C2825316:Service [Manufactured Object]
   736   C3245478:service [Idea or Concept]
   703 E C0183683:Support [Medical Device]
   703 E C3245459:veteran [Intellectual Product]

Phrase: "and"

Phrase: "the Bly Memorial Research Fund,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0681805:research fund [Research Activity]
   812   C0016820:Fund [Quantitative Concept]

Phrase: "University of Nebraska Medical Center."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0027523:Nebraska [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]
Processing 00000000.tx.175: 2 These authors contributed equally to this work. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "These authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]
Processing 00000000.tx.176: Received September 22, 2000.  

Phrase: "Received September 22,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "2000."
Processing 00000000.tx.177: References Top Abstract Introduction Materials and Methods Results Discussion References  Reaven GM 1988 Banting lecture 1988. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Reaven GM 1988 Banting lecture 1988."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376683:lecture [Intellectual Product]
   799   C0546866:GM [Antibiotic,Carbohydrate]
Processing 00000000.tx.178: Role of insulin resistance in human disease. 

Phrase: "Role of insulin resistance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in human disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.179: Diabetes 37:15951607[Abstract] McGarry JD 1992 What if Minkowski had been ageusic? 

Phrase: "Diabetes 37"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "15951607"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] McGarry JD 1992"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1549972:JD [Intellectual Product]

Phrase: "What"

Phrase: "if"

Phrase: "Minkowski"

Phrase: "had"

Phrase: "been"

Phrase: "ageusic?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C2364111:Ageusia [Sign or Symptom]
Processing 00000000.tx.180: An alternative angle on diabetes. 

Phrase: "An alternative angle on diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205143:Angle [Spatial Concept]
Processing 00000000.tx.181: Science 258:766770[Medline] Saloranta C, Groop L 1996 Interactions between glucose and FFA metabolism in man. 

Phrase: "Science 258"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "766770"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Saloranta C,"

Phrase: "Groop L 1996 Interactions between glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "FFA metabolism in man."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.182: Diabetes Metab Rev 12:1536[CrossRef][Medline] Boden G 1997 Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [published erratum appears in Diabetes 1997 Mar;46(3):536]. 

Phrase: "Diabetes Metab Rev 12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "1536"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Boden G 1997 Role of fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "NIDDM [published erratum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0282417:Published Erratum [Intellectual Product]

Phrase: "appears in Diabetes 1997"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
   770   C0700364:APPEAR [Qualitative Concept]

Phrase: "Mar"

Phrase: ";46"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ":"

Phrase: "536"

Phrase: "]."
Processing 00000000.tx.183: Diabetes 46:310[Abstract] Randle PJ, Garland PB, Newsholme EA, Hales CN 1965 The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "310"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Randle PJ,"

Phrase: "Garland PB,"

Phrase: "Newsholme EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Hales CN 1965"

Phrase: "The glucose fatty acid cycle in obesity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "maturity onset diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011860:Maturity-Onset Diabetes Mellitus [Disease or Syndrome]
           Maturity-Onset Diabetes
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
Processing 00000000.tx.184: Ann NY Acad Sci 131:324333[Medline] Thiebaud D, DeFronzo RA, Jacot E, Golay A, Acheson K, Maeder E, Jequier E, Felber JP 1982 Effect of long chain triglyceride infusion on glucose metabolism in man. 

Phrase: "Ann NY Acad Sci 131"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0027976:NY [Geographic Area]
   804   C0268596:ACAD [Disease or Syndrome]
   804   C1879958:NY [Intellectual Product]
   804   C2700624:ACAD [Cell Function]
   804   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "324333"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Thiebaud D,"

Phrase: "DeFronzo RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Jacot E,"

Phrase: "Golay A,"

Phrase: "Acheson K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Maeder E,"

Phrase: "Jequier E,"

Phrase: "Felber JP 1982 Effect of long chain triglyceride infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "on glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "in man."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024554:MAN [Finding]
  1000   C0025266:Man [Population Group]
  1000   C0086418:Man [Human]
Processing 00000000.tx.185: Metabolism 31:11281136[Medline] Bevilacqua S, Bonadonna R, Buzzigoli G, Boni C, Ciociaro D, Maccari F, Giorico MA, Ferrannini E 1987 Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. 

Phrase: "Metabolism 31"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
   861   C0450355:31 [Intellectual Product]

Phrase: ":"

Phrase: "11281136"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bevilacqua S,"

Phrase: "Bonadonna R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Buzzigoli G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Boni C,"

Phrase: "Ciociaro D,"

Phrase: "Maccari F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Giorico MA,"

Phrase: "Ferrannini E 1987 Acute elevation of free fatty acid levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0439775:Elevation [Therapeutic or Preventive Procedure]
   739   C0702240:Elevation [Spatial Concept]

Phrase: "leads to hepatic insulin resistance"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   762   C0332325:Resistant to [Functional Concept]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0205054:Hepatic [Body Location or Region]
   760   C0237834:Resistance [Mental Process]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1514892:Resistance [Physiologic Function]
   760   C1522538:Lead [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in obese subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.186: Metabolism 36:502506[Medline] Wolfe BM, Klein S, Peters EJ, Schmidt BF, Wolfe RR 1988 Effect of elevated free fatty acids on glucose oxidation in normal humans. 

Phrase: "Metabolism 36"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "502506"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wolfe BM,"

Phrase: "Klein S,"

Phrase: "Peters EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Schmidt BF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006409:BF [Geographic Area]
   861   C1824728:BF [Gene or Genome]

Phrase: "Wolfe RR 1988 Effect of elevated free fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "on glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "in normal humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Humans [Human]
Processing 00000000.tx.187: Metabolism 37:323329[Medline] Bevilacqua S, Buzzigoli G, Bonadonna R, Brandi LS, Oleggini M, Boni C, Geloni M, Ferrannini E 1990 Operation of Randles cycle in patients with NIDDM. 

Phrase: "Metabolism 37"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "323329"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bevilacqua S,"

Phrase: "Buzzigoli G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bonadonna R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Brandi LS,"

Phrase: "Oleggini M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Boni C,"

Phrase: "Geloni M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ferrannini E 1990 Operation of Randles cycle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0543467:Operation [Health Care Activity]
   748   C3241922:Operation [Activity]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with NIDDM."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011860:NIDDM [Disease or Syndrome]
  1000   C3273872:NIDDM [Gene or Genome]
Processing 00000000.tx.188: Diabetes 39:383389[Abstract] McGarry JD, Brown NF 1997 The mitochondrial carnitine palmitoyltransferase system. 

Phrase: "Diabetes 39"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "383389"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] McGarry JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Brown NF 1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "The mitochondrial carnitine palmitoyltransferase system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.189: From concept to molecular analysis. 

Phrase: "From concept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178566:concept [Idea or Concept]

Phrase: "to molecular analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1513380:Molecular Analysis [Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.190: Eur J Biochem 244:114[Abstract] Zammit VA 1999 The malonyl-CoA-long-chain acyl-CoA axis in the maintenance of mammalian cell function. 

Phrase: "Eur J Biochem 244"

Phrase: ":"

Phrase: "114"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Zammit VA 1999"

Phrase: "The malonyl-CoA-long-chain acyl-CoA axis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0522487:Long axis [Spatial Concept]
   795   C0004457:Axis [Body Part, Organ, or Organ Component]
   795   C0999597:Axis [Mammal]
   795   C1522496:Axis [Spatial Concept]
   710   C0001374:Long-Chain Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in the maintenance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintenance [Activity]

Phrase: "of mammalian cell function."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   901   C0007613:Cell Function [Cell Function]
   901   C1512977:Mammalian Cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705273:Function [Intellectual Product]
   827   C1948049:Cell [Spatial Concept]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.191: Biochem J 343 Pt 3:505515 Ruderman NB, Saha AK, Vavvas D, Witters LA 1999 Malonyl-CoA, fuel sensing, and insulin resistance. 

Phrase: "Biochem J 343 Pt 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C1515149:J 3 [Cell]

Phrase: ":"

Phrase: "505515 Ruderman NB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0919442:NB [Gene or Genome]
   827   C1705347:NB [Gene or Genome]

Phrase: "Saha AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Vavvas D,"

Phrase: "Witters LA 1999 Malonyl-CoA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0024645:Malonyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "fuel sensing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036658:sense [Organ or Tissue Function]

Phrase: "and"

Phrase: "insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.192: Am J Physiol 276:E1E18 McGarry JD, Leatherman GF, Foster DW 1978 Carnitine palmitoyltransferase I. 

Phrase: "Am"

Phrase: "J Physiol 276"

Phrase: ":"

Phrase: "E1E18 McGarry JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1549972:JD [Intellectual Product]

Phrase: "Leatherman GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]

Phrase: "Foster DW 1978 Carnitine palmitoyltransferase I."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0007262:Carnitine palmitoyltransferase 1 [Amino Acid, Peptide, or Protein,Enzyme]
           Carnitine Palmitoyltransferase
   861   C0085966:Carnitine Palmitoyltransferase I [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2258044:carnitine palmitoyltransferase I [Molecular Function]
   799   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   799   C0021966:I- [Inorganic Chemical]
   799   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0729572:Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.193: The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. 

Phrase: "The site of inhibition of hepatic fatty acid oxidation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C2945843:Site of [Qualitative Concept]
   742   C0205145:Site [Spatial Concept]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]

Phrase: "by malonyl-CoA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024645:Malonyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.194: J Biol Chem 253:41284136[Medline] Reddy JK, and Mannaerts GP 1994 Peroxisomal lipid metabolism. 

Phrase: "J Biol Chem 253"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "41284136"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Reddy JK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420098:JK [Gene or Genome]

Phrase: "and"

Phrase: "Mannaerts GP 1994 Peroxisomal lipid metabolism."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0598783:Lipid Metabolism [Molecular Function]
   827   C1517898:Lipid Metabolism [Molecular Function]
   799   C0023779:Lipid [Lipid]
   799   C0025519:Metabolism [Organism Function]
   799   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.195: Annu Rev Nutr 14:343370[CrossRef][Medline] Chen RF 1967 Removal of fatty acids from serum albumin by charcoal treatment. 

Phrase: "Annu Rev Nutr 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "343370"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chen RF 1967 Removal of fatty acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015252:Removal [Therapeutic or Preventive Procedure]
   748   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "from serum albumin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
  1000   C0728877:serum albumin [Laboratory or Test Result]
   861   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "by charcoal treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.196: J Biol Chem 242:173181[Abstract/Free FullText] Peavy DE, Edmondson JW, Duckworth WC 1984 Selective effects of inhibitors of hormone processing on insulin action in isolated hepatocytes. 

Phrase: "J Biol Chem 242"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "173181"

Phrase: "[Abstract/Free FullText"

Phrase: "] Peavy DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Edmondson JW,"

Phrase: "Duckworth WC 1984 Selective effects of inhibitors of hormone processing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in isolated hepatocytes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0227525:Hepatocytes [Cell]
   827 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.197: Endocrinology 114:753760[Abstract] Mannaerts GP, Debeer LJ, Thomas J, De Schepper PJ 1979 Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats. 

Phrase: "Endocrinology 114"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "753760"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mannaerts GP,"

Phrase: "Debeer LJ,"

Phrase: "Thomas J,"

Phrase: "De Schepper PJ 1979 Mitochondrial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0026237:Mitochondrial [Cell Component]
   804   C0521451:Mitochondrial [Functional Concept]

Phrase: "and"

Phrase: "peroxisomal fatty acid oxidation in liver homogenates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C1158366:fatty acid oxidation [Molecular Function]
   778   C0015684:Fatty acid [Lipid]
   774   C0015695:Fatty Liver [Disease or Syndrome]
   748   C0001128:Acid [Chemical]
   748   C0030011:Oxidation [Molecular Function]
   748   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "isolated hepatocytes from control"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0227525:Hepatocytes [Cell]
   737 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "clofibrate-treated rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.198: J Biol Chem 254:45854595[Abstract] Van Veldhoven PP, Brees C 1994 Isolation of rat liver peroxisomes by density gradient centrifugation. 

Phrase: "J Biol Chem 254"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "45854595"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Van Veldhoven PP,"

Phrase: "Brees C 1994 Isolation of rat liver peroxisomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0204727:Isolation [Therapeutic or Preventive Procedure]
   744   C0205409:Isolation [Functional Concept]
   744   C0220862:isolation [Laboratory Procedure]

Phrase: "by density gradient centrifugation."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0007704:Centrifugation, Density Gradient [Laboratory Procedure]
   827   C0007703:Centrifugation [Laboratory Procedure]
   827   C0178587:density [Quantitative Concept]
   827   C0439182:% gradient [Quantitative Concept]
   827   C0812409:Gradient [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.199: In: Latruffe N, Bugat M (eds) Peroxisomes, Springer-Verlag, New York, pp 512 Storrie B, Madden EA 1990 Isolation of subcellular organelles. 

Phrase: "In"

Phrase: ":"

Phrase: "Latruffe N,"

Phrase: "Bugat"

Phrase: "M ("

Phrase: "eds) Peroxisomes,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0752063:Peroxisomes [Cell Component]
   827 E C2984308:Peroxisome [Functional Concept]
   777 E C3546463:peroxisomal [Cell Component]

Phrase: "Springer-Verlag,"

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "pp 512 Storrie B,"

Phrase: "Madden"

Phrase: "EA 1990 Isolation of subcellular organelles."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0204727:Isolation [Therapeutic or Preventive Procedure]
   753   C0205409:Isolation [Functional Concept]
   753   C0220862:isolation [Laboratory Procedure]
Processing 00000000.tx.200: Methods Enzymol 182:203225[Medline] Lazarow PB 1981 Assay of peroxisomal beta-oxidation of fatty acids. 

Phrase: "Methods Enzymol 182"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "203225"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lazarow PB 1981 Assay of peroxisomal beta-oxidation of fatty acids."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0005507:Assay [Laboratory Procedure]
   738   C0243073:assay [Qualitative Concept]
   738   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.201: Methods Enzymol 72:315319[Medline] Small GM, Burdett K, Connock MJ 1985 A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. 

Phrase: "Methods Enzymol 72"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "315319"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Small GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Burdett K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Connock MJ 1985"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439254:MJ [Medical Device]

Phrase: "A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0005507:Assay [Laboratory Procedure]
   742   C0243073:assay [Qualitative Concept]
   742   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.202: Biochem J 227:205210[Medline] Moss DW 1984 Acid phosphatase. 

Phrase: "Biochem J 227"

Phrase: ":"

Phrase: "205210"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Moss DW 1984 Acid phosphatase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0001109:Acid Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0001128:Acid [Chemical]
   804   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0202406:Acid [Laboratory Procedure]
   804   C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.203: In: Bergmeyer HU (ed) Methods in Enzymatic Analysis. 

Phrase: "In"

Phrase: ":"

Phrase: "Bergmeyer HU (ed) Methods in Enzymatic Analysis."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   757   C2707190:Analysis method [Laboratory Procedure]
   748   C0025663:Methods [Intellectual Product]
   748   C0025664:methods [Intellectual Product]
   748   C0449851:Methods [Functional Concept]
   714 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.204: Verlag Chemie, Florida, pp 92106 Aronson Jr NN, Touster O 1974 Isolation of rat liver plasma membrane fragments in isotonic sucrose. 

Phrase: "Verlag Chemie,"

Phrase: "Florida,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016253:Florida [Geographic Area]

Phrase: "pp 92106 Aronson Jr NN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1850406:NN [Disease or Syndrome]

Phrase: "Touster O 1974 Isolation of rat liver plasma membrane"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C2247585:isolation membrane [Cell Component]
   742   C0204727:Isolation [Therapeutic or Preventive Procedure]
   742   C0205409:Isolation [Functional Concept]
   742   C0220862:isolation [Laboratory Procedure]

Phrase: "fragments in isotonic sucrose."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0332255:fragment [Functional Concept]
   770   C0486805:Fragments [Body Substance]
   770   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   770   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.205: Methods Enzymol 31:90102[CrossRef][Medline] Inestrosa NC, Bronfman M, Leighton F 1979 Detection of peroxisomal fatty acyl-coenzyme A oxidase activity. 

Phrase: "Methods Enzymol 31"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   827   C0450355:31 [Intellectual Product]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "90102"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Inestrosa NC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027964:NC [Geographic Area]
   861   C0028407:NC [Geographic Area]
   861   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Bronfman M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Leighton F 1979 Detection of peroxisomal fatty acyl-coenzyme A oxidase activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C2265875:detection of activity [Molecular Function]
   736   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.206: Biochem J 182:779788[Medline] Duckworth WC, Kitabchi AE 1974 Insulin and glucagon degradation by the same enzyme. 

Phrase: "Biochem J 182"

Phrase: ":"

Phrase: "779788"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Kitabchi AE 1974 Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucagon degradation by the same enzyme."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0678637:enzyme degradation [Laboratory Procedure]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
Processing 00000000.tx.207: Diabetes 23:536543[Medline] Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. 

Phrase: "Diabetes 23"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   861   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "536543"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bradford MM 1976"

Phrase: "A rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "sensitive method for the quantitation of microgram quantities of protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   741   C1547724:Quantity method [Idea or Concept]
   739   C0025663:Method [Intellectual Product]
   739   C0449851:Method [Functional Concept]
   739   C0871511:METHOD [Intellectual Product]

Phrase: "utilizing"

Phrase: "the principle of protein-dye binding."
Processing 00000000.tx.208: Anal Biochem 72:248254[CrossRef][Medline] Bennett RG, Hamel FG, Duckworth WC 1994 Identification and isolation of a cytosolic proteolytic complex containing insulin degrading enzyme and the multicatalytic proteinase. 

Phrase: "Anal Biochem 72"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003461:Anal [Body Part, Organ, or Organ Component]
   827   C2939124:Anal [Spatial Concept]

Phrase: ":"

Phrase: "248254"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Duckworth WC 1994 Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0020792:Identification [Mental Process]
   812   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "isolation of a cytosolic proteolytic complex containing insulin degrading enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0204727:Isolation [Therapeutic or Preventive Procedure]
   739   C0205409:Isolation [Functional Concept]
   739   C0220862:isolation [Laboratory Procedure]

Phrase: "and"

Phrase: "the multicatalytic proteinase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:Multicatalytic Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2258865:multicatalytic proteinase [Molecular Function]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.209: Biochem Biophys Res Commun 202:10471053[CrossRef][Medline] Duckworth WC, Bennett RG, Hamel FG 1998 Insulin acts intracellularly on proteasomes through insulin-degrading enzyme. 

Phrase: "Biochem Biophys Res Commun 202"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "10471053"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG 1998 Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "intracellularly on proteasomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   756 E C1325620:proteasome [Cell Component]
   756 E C1752727:Proteasome [Molecular Function]

Phrase: "through insulin-degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.210: Biochem Biophys Res Commun 244:390394[CrossRef][Medline] Florkowski CM, Scott RS 1999 Type 2 diabetes towards the new millenniumthe relative importance of glycaemic versus lipid control. 

Phrase: "Biochem Biophys Res Commun 244"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "390394"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Florkowski CM,"

Phrase: "Scott RS 1999 Type 2 diabetes towards the new millenniumthe relative importance of glycaemic"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   763   C0011860:Type 2 Diabetes [Disease or Syndrome]
   748   C0441730:Type 2 [Classification]
   747   C1320657:Diabetes type [Finding]
   747   C1554124:New type [Idea or Concept]
   734   C0011847:Diabetes [Disease or Syndrome]
   734   C0011849:Diabetes [Disease or Syndrome]
   734   C0332307:Type [Qualitative Concept]
   734   C1547052:*Type [Quantitative Concept]

Phrase: "versus"

Phrase: "lipid control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.211: Aust N Z J Med 29:249253[Medline] Boden G 1999 Free fatty acids, insulin resistance, and type 2 diabetes mellitus. 

Phrase: "Aust N Z J Med 29"

Phrase: ":"

Phrase: "249253"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Boden G 1999 Free fatty acids,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0015688:Free Fatty Acids [Lipid]
   827   C0015684:Fatty Acids [Lipid]
   827 E C2698488:Free Fatty Acid [Laboratory Procedure]
   799   C0001128:Acids [Chemical]
   799   C0332296:free [Functional Concept]
   799   C1880497:Free [Qualitative Concept]
   799   C1996904:Free [Qualitative Concept]
   766 E C0202406:Acid [Laboratory Procedure]

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "type 2 diabetes mellitus."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
  1000   C2984301:Type II diabetes mellitus [Functional Concept]
   875   C1320657:type diabetes [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.212: Proc Assoc Am Physicians 111:241248[Medline] Baumeister H, Muller D, Rehbein M, Richter D 1993 The rat insulin-degrading enzyme. 

Phrase: "Proc Assoc"

Phrase: "Am"

Phrase: "Physicians 111"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031831:Physicians [Professional or Occupational Group]
   827 E C0804815:Physician [Clinical Attribute]

Phrase: ":"

Phrase: "241248"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Baumeister H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Muller D,"

Phrase: "Rehbein M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Richter D 1993"

Phrase: "The rat insulin-degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.213: Molecular cloning and characterization of tissue-specific transcripts. 

Phrase: "Molecular cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "characterization of tissue-specific transcripts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]
Processing 00000000.tx.214: FEBS Lett 317:250254[CrossRef][Medline] Kuo WL, Gehm BD, Rosner MR, Li W, Keller G 1994 Inducible expression and cellular localization of insulin-degrading enzyme in a stably transfected cell line. 

Phrase: "FEBS Lett 317"

Phrase: ":"

Phrase: "250254"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kuo WL,"

Phrase: "Gehm BD,"

Phrase: "Rosner MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Li W,"

Phrase: "Keller G 1994 Inducible expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cellular localization of insulin-degrading enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1660642:cellular localisation [Cell Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "in a stably transfected cell line."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0007600:Cell Line [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.215: J Biol Chem 269:2259922606[Abstract/Free FullText] Gould SJ, Keller GA, Hosken N, Wilkinson J, Subramani S 1989 A conserved tripeptide sorts proteins to peroxisomes. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2259922606"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gould SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Keller GA,"

Phrase: "Hosken N,"

Phrase: "Wilkinson J,"

Phrase: "Subramani S 1989"

Phrase: "A conserved tripeptide"

Phrase: "sorts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237886:sort [Mental Process]
  1000   C0700314:sort [Cell Function]
  1000   C1947906:Sort [Activity]

Phrase: "proteins to peroxisomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.216: J Cell Biol 108:16571664[Abstract] Authier F, Rachubinski RA, Posner BI, Bergeron JJ 1994 Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme. 

Phrase: "J Cell Biol 108"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "16571664"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Rachubinski RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron JJ 1994 Endosomal proteolysis of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597304:Proteolysis [Molecular Function]

Phrase: "by an acidic thiol metalloprotease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "unrelated to insulin degrading enzyme."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0445356:Unrelated [Finding]
   760   C1704623:Unrelated [Qualitative Concept]
Processing 00000000.tx.217: J Biol Chem 269:30103016[Abstract/Free FullText] Hamel FG, Bennett RG, Harmon KS, Duckworth WC 1997 Insulin inhibition of proteasome activity in intact cells. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "30103016"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Harmon KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Duckworth WC 1997 Insulin inhibition of proteasome activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "in intact cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.218: Biochem Biophys Res Commun 234:671674[CrossRef][Medline] Bennett RG, Hamel FG, Duckworth WC 2000 Insulin inhibits the ubiquitin-dependent degrading activity of the 26S proteasome. 

Phrase: "Biochem Biophys Res Commun 234"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "671674"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Duckworth WC 2000 Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the ubiquitin-dependent degrading activity of the 26S proteasome."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C1325411:ubiquitin activity [Molecular Function]
   762   C1622946:proteasome activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.219: Endocrinology 141:25082517[Abstract/Free FullText] Bennett RG, Hamel FG, Duckworth WC 1997 Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex [published erratum appears in Diabetes 1997 Sep;46(9):1532]. 

Phrase: "Endocrinology 141"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "25082517"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Duckworth WC 1997 Characterization of the insulin inhibition of the peptidolytic activities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1880022:Characterization [Activity]

Phrase: "of the insulin-degrading enzyme-proteasome complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0439855:Complex [Qualitative Concept]
   804   C1704241:Complex [Chemical Viewed Structurally]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "[published erratum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282417:Published Erratum [Intellectual Product]

Phrase: "appears in Diabetes 1997 Sep;46"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0700364:APPEAR [Qualitative Concept]
   753   C1418664:SEP [Gene or Genome]
   753   C1419968:SeP [Gene or Genome]
   753   C1826261:SEP [Gene or Genome]

Phrase: "(9"

Phrase: ")"

Phrase: ":"

Phrase: "1532"

Phrase: "]."
Processing 00000000.tx.220: Diabetes 46:197203[Abstract] Kupfer SR, Marschke KB, Wilson EM, French FS 1993 Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "197203"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kupfer SR,"

Phrase: "Marschke KB,"

Phrase: "Wilson EM,"

Phrase: "French FS 1993 Receptor accessory factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1521761:Factor [Functional Concept]
   799   C2827422:Factor [Conceptual Entity]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "specific DNA binding of androgen"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1148673:DNA Binding [Genetic Function]
   797   C1148623:androgen binding [Molecular Function]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "glucocorticoid receptors."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   966 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017710:Glucocorticoid [Hormone,Steroid]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.221: J Biol Chem 268:1751917527[Abstract/Free FullText] Kupfer SR, Wilson EM, French FS 1994 Androgen and glucocorticoid receptors interact with insulin degrading enzyme. 

Phrase: "J Biol Chem 268"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1751917527"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kupfer SR,"

Phrase: "Wilson EM,"

Phrase: "French FS 1994 Androgen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0002844:Androgen [Hormone,Pharmacologic Substance]
   812   C3536949:Androgen [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucocorticoid receptors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0034809:Receptors, Glucocorticoid [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
   966 E C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017710:Glucocorticoid [Hormone,Steroid]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "interact with insulin degrading enzyme."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.222: J Biol Chem 269:2062220628[Abstract/Free FullText] Fakhrai-Rad H, Nikoshkov A, Kamel A, Fernstrom M, Zierath JR, Norgren S, Luthman H, Galli J 2000 Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2062220628"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fakhrai-Rad H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Nikoshkov A,"

Phrase: "Kamel A,"

Phrase: "Fernstrom M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zierath JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Norgren S,"

Phrase: "Luthman H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Galli J 2000 Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C0014445:enzymes [Functional Concept]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "identified as a candidate diabetes susceptibility gene"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0919453:Susceptibility Gene [Gene or Genome]
   774   C1332838:Candidate Gene [Gene or Genome]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0012655:Susceptibility [Clinical Attribute]
   748   C0017337:Gene [Gene or Genome]
   748   C0205396:Identified [Qualitative Concept]
   748   C0220898:Susceptibility [Organism Attribute]
   748   C1264642:Susceptibility [Functional Concept]
   748   C1547045:*Susceptibility [Quantitative Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]

Phrase: "in GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.223: Hum Mol Genet 9:21492158[Abstract/Free FullText] Escher P, Wahli W 2000 Peroxisome proliferator-activated receptors: insight into multiple cellular functions. 

Phrase: "Hum Mol Genet 9"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "21492158"

Phrase: "[Abstract/Free FullText"

Phrase: "] Escher P,"

Phrase: "Wahli W 2000 Peroxisome proliferator-activated receptors"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   877   C0166418:Peroxisome Proliferator-Activated Receptors [Amino Acid, Peptide, or Protein,Receptor]
   866 E C1418776:PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [Gene or Genome]
   818   C0600434:peroxisome proliferator [Hazardous or Poisonous Substance]
   795   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   795   C0752063:Peroxysome [Cell Component]
   795   C1879547:Activated [Activity]
   795   C2984308:Peroxisome [Functional Concept]
   762 E C1515877:Activate [Functional Concept]
   724 E C3546463:peroxisomal [Cell Component]

Phrase: ":"

Phrase: "insight into multiple cellular functions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0233820:Insight, function [Mental Process]
           Insight
Processing 00000000.tx.224: Mutat Res 448:121138[Medline] Johnson TE, Holloway MK, Vogel R, Rutledge SJ, Perkins JJ, Rodan GA, Schmidt A 1997 Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator-activated receptors. 

Phrase: "Mutat Res 448"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "121138"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Johnson TE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039462:Te [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C1705540:TE [Conceptual Entity]

Phrase: "Holloway MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Vogel R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rutledge SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Perkins JJ,"

Phrase: "Rodan GA,"

Phrase: "Schmidt"

Phrase: "A 1997 Structural requirements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1514873:Requirement [Functional Concept]

Phrase: "and"

Phrase: "cell-type specificity for ligand activation of peroxisome proliferator-activated receptors."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   770   C0449475:Type of cell [Intellectual Product]
           cell type
   756   C0007634:Cell Type [Cell]
           Cell
   754   C1326120:cell activation [Cell Function]
   738   C0037791:Specificity [Quantitative Concept]
   738   C0332307:Type [Qualitative Concept]
   738   C1269647:Cell [Cell]
   738   C1511884:Specificity [Quantitative Concept]
   738   C1547052:*Type [Quantitative Concept]
   738   C1704653:Cell [Medical Device]
   738   C1948049:Cell [Spatial Concept]
   737   C1514760:Receptor Cell [Cell]
Processing 00000000.tx.225: J Steroid Biochem Mol Biol 63:18[CrossRef][Medline] Schmidt A, Vogel RL, Witherup KM, Rutledge SJ, Pitzenberger SM, Adam M, Rodan GA 1996 Identification of fatty acid methyl ester as naturally occurring transcriptional regulators of the members of the peroxisome proliferator-activated receptor family. 

Phrase: "J Steroid Biochem Mol Biol 63"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   858   C2346604:J/mol [Quantitative Concept]
   799   C0027960:Mole [Neoplastic Process]
   799   C0038317:Steroid [Steroid]
   799   C0324740:Mole [Mammal]
   799   C0439189:Mole [Quantitative Concept]
   799   C1456781:mole [Neoplastic Process]
   799   C1824986:mol [Gene or Genome]
   716 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "18"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schmidt A,"

Phrase: "Vogel RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Witherup KM,"

Phrase: "Rutledge SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Pitzenberger SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Adam M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Rodan GA 1996 Identification of fatty acid methyl ester"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0020792:Identification [Mental Process]
   742   C0205396:Identification [Qualitative Concept]

Phrase: "as"

Phrase: "naturally"

Phrase: "occurring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709305:Occur [Activity]
   966   C2745955:OCCUR [Temporal Concept]

Phrase: "transcriptional regulators of the members of the peroxisome proliferator-activated receptor family."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   736   C0040649:Transcriptional [Genetic Function]
   736   C0182953:regulators [Medical Device]
   703 E C1704734:Regulator [Medical Device]
   703 E C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.226: Lipids 31:11151124[Medline] Roche E, Buteau J, Aniento I, Reig JA, Soria B, Prentki M 1999 Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic beta-cell line INS-1. 

Phrase: "Lipids 31"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023779:Lipids [Lipid]
   861   C0450355:31 [Intellectual Product]

Phrase: ":"

Phrase: "11151124"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Roche E,"

Phrase: "Buteau J,"

Phrase: "Aniento I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Reig JA,"

Phrase: "Soria B,"

Phrase: "Prentki M 1999 Palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030233:palmitate [Lipid]
   812   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "and"

Phrase: "oleate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0133788:oleate [Lipid]
  1000   C0220884:Oleate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the immediate-early response genes c-fos"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C1415884:IMMEDIATE-EARLY RESPONSE GENE [Gene or Genome]
   700   C0206256:Genes, Immediate-Early [Gene or Genome]

Phrase: "and"

Phrase: "nur-77 in the pancreatic beta-cell line"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   800   C0030281:Pancreatic beta cell [Cell]
           Beta cell
   770   C0007600:Cell Line [Cell]
   744   C0007634:Cell [Cell]
   744   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   744   C0205132:Line [Spatial Concept]
   744   C0330390:Beta [Plant]
   744   C0439096:Beta [Intellectual Product]
   744   C1269647:Cell [Cell]
   744   C1550648:Line [Substance]
   744   C1552960:Line [Quantitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2004068:Beta [Qualitative Concept]

Phrase: "INS-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.227: Diabetes 48:20072014[Abstract] Hertz R, Magenheim J, Berman I, Bar-Tana J 1998 Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "20072014"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hertz R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Magenheim J,"

Phrase: "Berman I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Bar-Tana J 1998 Fatty acyl-CoA thioesters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597572:thioester [Organic Chemical]

Phrase: "are"

Phrase: "ligands of hepatic nuclear factor-4."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0023688:Ligands [Chemical]
Processing 00000000.tx.228: Nature 392:512516[CrossRef][Medline] Black PN, Faergeman NJ, DiRusso CC 2000 Long-chain acyl-CoA-dependent regulation of gene expression in bacteria, yeast and mammals. 

Phrase: "Nature 392"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "512516"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Black PN,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600785:Black PN [Organic Chemical,Pharmacologic Substance]
   861   C3539925:PN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C3541307:PN [Gene or Genome]

Phrase: "Faergeman NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "DiRusso CC 2000 Long-chain acyl-CoA-dependent regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0851285:Regulation [Governmental or Regulatory Activity]
   791   C1327622:Regulation [Biologic Function]

Phrase: "of gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in bacteria,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0004611:Bacteria [Bacterium]
  1000   C1510439:bacteria [Functional Concept]
  1000   C2347473:% Bacteria [Quantitative Concept]
   928 E C0521009:Bacterial [Qualitative Concept]

Phrase: "yeast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "mammals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024660:Mammals [Mammal]
Processing 00000000.tx.229: J Nutr 130:305S309S[Abstract/Free FullText] Faergeman NJ, Knudsen J 1997 Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling. 

Phrase: "J Nutr 130"

Phrase: ":"

Phrase: "305S309S"

Phrase: "[Abstract/Free FullText"

Phrase: "] Faergeman NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Knudsen J 1997 Role of long-chain fatty acyl-CoA esters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "in cell signalling."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C3537152:signalling [Biologic Function]
   793 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.230: Biochem J 323:112[Medline] Shrago E 2000 Long-chain acyl-CoA as a multi-effector ligand in cellular metabolism. 

Phrase: "Biochem J 323"

Phrase: ":"

Phrase: "112"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shrago E 2000 Long-chain acyl-CoA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   877   C0001374:Long-Chain Acyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
           Acyl CoA

Phrase: "as a multi-effector ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023688:Ligand [Chemical]

Phrase: "in cellular metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1524026:cellular metabolism [Cell Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.231: J Nutr 130:290S293S[Abstract/Free FullText]

Phrase: "J Nutr 130"

Phrase: ":"

Phrase: "290S293S"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

